US20020015758A1 - Composition comprising pectin methyl esterase and two substrates - Google Patents

Composition comprising pectin methyl esterase and two substrates Download PDF

Info

Publication number
US20020015758A1
US20020015758A1 US09/403,345 US40334599A US2002015758A1 US 20020015758 A1 US20020015758 A1 US 20020015758A1 US 40334599 A US40334599 A US 40334599A US 2002015758 A1 US2002015758 A1 US 2002015758A1
Authority
US
United States
Prior art keywords
pme
pectin
substrate
plant
mash
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/403,345
Other versions
US6368642B2 (en
Inventor
Jette Kreiberg
Tove Christensen
Susanne Hyttel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DuPont Nutrition Biosciences ApS
Original Assignee
Danisco AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco AS filed Critical Danisco AS
Assigned to DANISCO A/S reassignment DANISCO A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHRISTENSEN, TOVE MARTEL IDA ELSA, HYTTEL, SUSANNE, KREIBERG, JETTE DINA
Publication of US20020015758A1 publication Critical patent/US20020015758A1/en
Application granted granted Critical
Publication of US6368642B2 publication Critical patent/US6368642B2/en
Assigned to DUPONT NUTRITION BIOSCIENCES APS reassignment DUPONT NUTRITION BIOSCIENCES APS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DANISCO A/S
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • A23L21/10Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products
    • A23L21/12Marmalades; Jams; Jellies; Other similar fruit or vegetable compositions; Simulated fruit products derived from fruit or vegetable solids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231Pectin; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01011Pectinesterase (3.1.1.11)

Definitions

  • the present invention relates to a composition.
  • the present invention relates to a composition for use as or in the preparation of a foodstuff. More in particular, the present invention relates to a composition for use as or in the preparation of a foodstuff comprising or made from a pectin or a pectin derivative.
  • Pectin is an important commodity in today's industry. For example, it can be used in the food industry as a thickening or gelling agent, such as in the preparation of jams.
  • Pectin is a structural polysaccharide commonly found in the form of protopectin in plant cell walls.
  • the backbone of pectin comprises ⁇ -1-4 linked galacturonic acid residues which are interrupted with a small number of 1,2 linked ⁇ -L-rhamnose units.
  • pectin comprises highly branched regions with an almost alternating rhamno-galacturonan chain. These highly branched regions also contain other sugar units (such as D-galactose, L-arabinose and xylose) attached by glycosidic linkages to the C3 or C4 atoms of the rhamnose units or the C2 or C3 atoms of the galacturonic acid units.
  • the long chains of ⁇ -1-4 linked galacturonic acid residues are commonly referred to as “smooth” regions, whereas the highly branched regions are commonly referred to as the “hairy regions”.
  • carboxyl groups of the galacturonic residues are esterified (e.g. the carboxyl groups are methylated).
  • esterification of the carboxyl groups occurs after polymerisation of the galacturonic acid residues.
  • it is extremely rare for all of the carboxyl groups to be esterified e.g. methylated.
  • the degree of esterification will vary from 0-90%. If 50% or more of the carboxyl groups are esterified then the resultant pectin is referred to as a “high ester pectin” (“HE pectin” for short) or a “high methoxyl pectin”.
  • the resultant pectin is referred to as a “low ester pectin” (“LE pectin” for short) or a “low methoxyl pectin”. If 50% of the carboxyl groups are esterified then the resultant pectin is referred to as a “medium ester pectin” (“ME pectin” for short) or a “medium methoxyl pectin”. If the pectin does not contain any—or only a few—esterified groups it is usually referred to as pectic acid.
  • pectin gelation depends on the chemical nature of the pectin, especially the degree of esterification.
  • pectin gelation also depends on the soluble-solids content, the pH and calcium ion concentration. With respect to the latter, it is believed that the calcium ions form complexes with free carboxyl groups, particularly those on a LE pectin.
  • Pectic enzymes are classified according to their mode of attack on the galacturonan part of the pectin molecule.
  • a review of some pectic enzymes has been prepared by Pilnik and Voragen (Food Enzymology, Ed.: P. F. Fox; Elsevier; (1991); pp: 303-337).
  • pectin methylesterases EC 3.1.1.11
  • PMEs de-esterify HE pectins to LE pectins or pectic acids.
  • pectin depolymerases split the glycosidic linkages between galacturonosyl methylester residues.
  • PME activity produces free carboxyl groups and free methanol.
  • the increase in free carboxyl groups can be easily monitored by automatic titration.
  • PMEs de-esterify pectins in a random manner, in the sense that they de-esterify any of the esterified (e.g. methylated) galacturonic acid residues on one or more than one of the pectin chains.
  • Examples of PMEs that randomly de-esterify pectins may be obtained from fungal sources such as Aspergillus aculeatus (see WO 94/25575) and Aspergillus japonicus (Ishii et al 1980 J Food Sci 44 pp 611-14).
  • PMEs are known to de-esterify pectins in a block-wise manner, in the sense that it is believed they attack pectins either at non-reducing ends or next to free carboxyl groups and then proceed along the pectin molecules by a single-chain mechanism, thereby creating blocks of un-esterified galacturonic acid units which can be calcium sensitive.
  • Examples of such enzymes that block-wise enzymatically de-esterify pectin are plant PMEs. Up to 12 isoforms of PME have been suggested to exist in citrus (Pilnik W. and Voragen A. G. J. (Food Enzymology (Ed.: P. F. Fox); Elsevier; (1991); pp: 303-337). These isoforms have different properties.
  • Random or blockwise distribution of free carboxyl groups can be distinguished by high performance ion exchange chromatography (Schols et al Food Hydrocolloids 1989 6 pp 115-121). These tests are often used to check for undesirable, residual PME activity in citrus juices after pasteurisation because residual PME can cause, what is called, “cloud loss” in orange juice in addition to a build up of methanol in the juice.
  • PME substrates such as pectins obtained from natural plant sources, are generally in the form of a high ester pectin having a DE of about 70%. Sugar must be added to extracts containing these high ester PME substrates to provide sufficient soluble solids to induce gelling. Usually a minimum of 55% soluble solids is required. Syneresis tends to occur more frequently when the percentage soluble solids is less than 55%. When syneresis does occur, expensive additives must be used to induce gelling.
  • Isoform I has a molecular weight of 36000 D, an isoelectric point of 10.0, an optimum pH of 7.6 and a K m value (mg/ml) of 0.083.
  • Isoform II has a molecular weight of 36200 D, an isoelectric point or 11.0, an optimum pH of 8.8 and a K m value (mg/ml) of 0.0046.
  • Isoform III (HMW-PE) has a molecular weight of 54000 D, an isoelectric point of 10.2, an optimum pH of 8 and a K m value (mg/ml) of 0.041.
  • PMEs molecular weight
  • PMEs may be found in a number of other higher plants, such as apple, apricot, avocado, banana, berries, lime, grapefruit, mandarin, cherries, currants, grapes, mango, papaya, passion fruit, peach, pear, plums, beans, carrots, cauliflower, cucumber, leek, onions, pea, potato, radish and tomato.
  • apple apricot
  • avocado, banana, berries, lime, grapefruit, mandarin, cherries, currants, grapes, mango papaya, passion fruit, peach, pear, plums, beans, carrots, cauliflower, cucumber, leek, onions, pea, potato, radish and tomato.
  • a plant PME has been reported in WO-A-97/03574 (the contents of which are incorporated herein by reference).
  • This PME has the following characteristics: a molecular weight of from about 36 kD to about 64 kD; a pH optimum of pH 7-8 when measured with 0.5% lime pectin in 0.15 M NaCl; a temperature optimum of at least 50° C.; a temperature stability in the range of from 10°—at least 40° C.; a K m value of 0.07%; an activity maximum at levels of about 0.25 M NaCl; an activity maximum at levels of about 0.2 M Na 2 SO 4 ; and an activity maximum at levels of about 0.3 M NaNO 3 .
  • PMEs have important uses in industry. For example, they can be used in or as sequestering agents for calcium ions.
  • cattle feed can be prepared by adding a slurry of calcium hydroxide to citrus peels after juice extraction. After the addition, the high pH and the calcium ions activate any native PME in the peel causing rapid de-esterification of the pectin and calcium pectate coagulation occurs. Bound liquid phase is released and is easily pressed out so that only a fraction of the original water content needs to be removed by expensive thermal drying. The press liquor is then used as animal feed.
  • a PME has been obtained from Aspergillus aculeatus (WO 94/25575). Apparently, this PME can be used to improve the firmness of a pectin-containing material, or to de-methylate pectin, or to increase the viscosity of a pectin-containing material.
  • PME in the preparation of foodstuffs prepared from fruit or vegetable materials containing pectin—such as jams or preservatives.
  • WO-A-94/25575 further reports on the preparation of orange marmalade and tomato paste using PME obtained from Aspergillus aculeatus.
  • JP-A-63/209553 discloses gels which are obtained by the action of pectin methylesterase, in the presence of a polyvalent metal ion, on a pectic polysaccharide containing as the main component a high-methoxyl poly ⁇ -1,4-D-galacturonide chain and a process for their production.
  • Pilnik and Voragen list uses of endogenous PMEs which include their addition to fruit juices to reduce the viscosity of the juice if it contains too much pectin derived from the fruit, their addition as pectinase solutions to the gas bubbles in the albedo of citrus fruit that has been heated to a core temperature of 20° C. to 40° C. in order to facilitate removal of peel and other membrane from intact juice segments (U.S. Pat. No.
  • EP-A-0664300 discloses a chemical fractionation method for preparing calcium sensitive pectin. This calcium sensitive pectin is said to be advantageous for the food industry.
  • pectins and de-esterified pectins in addition to PMEs, have an industrial importance.
  • a benefit derived from use of a PME in the preparation of, for example, a foodstuff will depend to some extent on the quality and quantity and type of the PME used and on the quality and quantity and type of the PME substrates—in particular pectin—that may be present in the material used to prepare the foodstuff.
  • the substrate is a fruit material or a vegetable material
  • the amount and/or structure of natural pectin in that substrate will be different for different types of fruit material or vegetable material. This is also borne out by the data presented in WO-A-94/25575, especially FIG. 7 where it is clear to see that its PME system is not ideal.
  • addition of an additional PME substrate will overcome any problems associated with differing quantities and qualities of PME substrates that may be found in materials used in the preparation of, for example, foodstuffs.
  • a composition comprising a pectin methyl esterase (“PME”); a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • PME pectin methyl esterase
  • a method of preparing a composition comprising forming a mixture of a PME; a first PME substrate, and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • a process comprising adding to a first PME substrate, PME and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • a foodstuff comprising or prepared from or by the other aspects of the present invention.
  • a composition made from a pectin methyl esterase (“PME”); a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • PME pectin methyl esterase
  • a process of imparting stability to a reaction medium comprising a first PME substrate comprising adding at least PME and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • the present invention provides a composition comprising a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • the term “neither the first PME substrate nor the second PME substrate originates in situ from the other” means that the first PME substrate does not originate in situ from the second PME substrate and/or the second PME substrate does not originate from the first PME substrate.
  • the first PME substrate has not been derived in situ from the second PME substrate and vice versa.
  • the composition of the present invention does not encompass just a quantity of a first PME substrate wherein a portion of that PME substrate has been partially modified by a PME enzyme.
  • a second PME substrate must be also present—wherein that second PME substrate has not originated in situ from the first PME substrate.
  • composition of the present invention there can be present additional, different PME substrate(s).
  • the PME substrates in or for the composition of the present invention may be obtainable from different sources and/or may be of different chemical composition.
  • composition of the present invention there can be present additional, different PME enzyme(s).
  • the PME enzymes may be obtainable from different sources and/or may be of different composition and/or may have a different reactivity profile (e.g. different pH optimum and/or different temperature optimum).
  • the PME enzyme may de-esterify the PME substrates in a random manner or in a block-wise manner. If there is more than one PME, then each PME is independently selected from a PME that can de-esterify the PME substrate(s) in a random manner or a PME that can de-esterify the PME substrate(s) in a block-wise manner.
  • the (or at least one) PME enzyme de-esterifies the PME substrate(s) in a block-wise manner.
  • each PME is independently selected from a PME enzyme that is sensitive to sodium ions (Na-sensitive) or a PME enzyme that is insensitive to sodium ions (Na-insensitive).
  • the (or at least one) PME enzyme is a PME enzyme that is Na-sensitive.
  • the PME may be obtainable from natural sources or even obtained from natural sources or it may be chemically synthesised.
  • the PME may be obtainable from a fungus, such as by way of example a PME of fungal origin (i.e. a PME that has been obtained from a fungus).
  • a PME of fungal origin i.e. a PME that has been obtained from a fungus.
  • the PME may be obtainable from a bacterium, such as by way of example a PME of bacterial origin (i.e. a PME that has been obtained from a bacterium).
  • the PME may be obtainable from a plant, such as by way of example a PME of plant origin (i.e. a PME that has been obtained from a plant).
  • the PME is prepared by use of recombinant DNA techniques.
  • the PME can be a recombinant PME as disclosed in WO-A-97/03574 or the PME disclosed in either WO-A-94/25575 or WO-A-97/31102 as well as variants, derivatives or homologues of the sequences disclosed in those patent applications.
  • the PME is the recombinant PME of WO-A-97/03574 (the contents of which are incorporated herein by reference)—such as the PME of SEQ.I.D. No. 1 or SEQ.I.D. No. 2 (which are coded by the nucleotide sequences presented as SEQ.I.D. No. 3 and SEQ.I.D. No. 4 respectively) or a variant, derivative or homologue thereof; and/or the PME of WO-A-94/25575 (the contents of which are incorporated herein by reference), or a variant, derivative or homologue thereof.
  • variant in relation to the recombinant enzyme of the present invention include any substitution of, variation of, modification of, replacement of, deletion of or addition of one (or more) amino acid from or to the sequence providing the resultant amino acid sequence has PME activity, preferably having at least the same activity of a recombinant enzyme comprising any one or more of the sequences shown as SEQ I.D. No.s 1 and 2.
  • homologue covers homology with respect to structure and/or function providing the resultant recombinant enzyme has PME activity. With respect to sequence homology (i.e.
  • variant in relation to the nucleotide sequence coding for the recombinant enzyme of the present invention include any substitution of, variation of, modification of, replacement of, deletion of or addition of one (or more) nucleic acid from or to the sequence providing the resultant nucleotide sequence codes for a recombinant enzyme having PME activity, preferably having at least the same activity of a recombinant enzyme comprising any one or more of the sequences shown as SEQ I.D. No.s 1 and 2.
  • the term “homologue” covers homology with respect to structure and/or function providing the resultant nucleotide sequence codes for a recombinant enzyme having PME activity. With respect to sequence homology (i.e. similarity), preferably there is at least 75%, more preferably at least 85%, more preferably at least 90% homology. More preferably there is at least 95%, more preferably at least 98%, homology.
  • At least one of the PME substrates is pectin or is a substrate that is derivable from or derived from pectin (eg. a pectin derivative).
  • the term “derived from pectin” includes derivatised pectin, degraded (such as partially degraded) pectin and modified pectin.
  • An example of a modified pectin is pectin that has been prior treated with an enzyme such as a PME.
  • An example of a pectin derivative is pectin that has been chemically treated—eg. amidated.
  • each of the first PME substrate and the second PME substrate is independently selected from pectin, a substrate that is derivable from pectin, or a substrate that is derived from pectin.
  • each of the first PME substrate and the second PME substrate is pectin.
  • either the first PME substrate or the second PME substrate is a modified pectin—in particular an enzymatically modified pectin, preferably a PME treated pectin.
  • the second PME substrate is such a modified pectin.
  • each of the first PME substrate and the second PME substrate is such a modified pectin.
  • the first PME substrate is present within (i.e. in situ) a plant or a plant material.
  • the plant may be a transgenic plant, such as a plant that has been genetically engineered to produce different levels and/or types of pectin.
  • the plant material may be obtained from a transgenic plant, such as a plant that has been genetically engineered to produce different levels and/or types of pectin.
  • the plant or plant material may be or may be derived from a vegetable, a fruit, or other type of pectin containing or producing plant.
  • the plant material is a vegetable material and/or a fruit material.
  • the vegetable material and/or the fruit material is a mash.
  • the first PME substrate and/or the second PME substrate can be any one or more of a low ester pectin, a medium ester pectin or a high ester pectin.
  • the second PME substrate is a low ester pectin, a medium ester pectin or a high ester pectin.
  • a Protocol for determining the degree of esterification of the PME substrate may be found on page 58 of WO-A-97/03574 (the contents of which are incorporated herein by reference). For ease of reference, this Protocol is recited in the Examples section (infra).
  • the second PME substrate is a high ester pectin.
  • the first PME substrate and the second PME substrate are independently selected from a PME substrate that is sensitive to calcium ions (Ca-sensitive) or a PME substrate that is insensitive to calcium ions (Ca-insensitive).
  • Ca-sensitive a PME substrate that is sensitive to calcium ions
  • Ca-insensitive a PME substrate that is insensitive to calcium ions
  • the second PME substrate is Ca-sensitive.
  • the second PME substrate is added to the First PME substrate.
  • the term “added to” includes physically adding the second PME substrate to the first PME substrate and vice versa.
  • the PME may be added at the same time as the second PME substrate, or before the addition of the second PME substrate or after the addition of the second PME substrate.
  • the present invention encompasses at least the following possibilities: adding PME to the first PME substrate and at the same time as the second PME substrate; adding PME to the second PME substrate and at the same time as the first PME substrate; adding the second PME substrate to PME and at the same time as the first PME substrate; adding PME and the first PME substrate and the second PME substrate at the same time to a reaction vessel; incubating the first PME substrate with PME prior to addition to the second PME substrate; incubating the second PME substrate with PME prior to addition to the first PME substrate; incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding a further
  • the present invention comprises any one or more of: adding PME to the first PME substrate and at the same time as the second PME substrate; adding PME to the second PME substrate and at the same time as the first PME substrate; adding the second PME substrate to PME and at the same time as the first PME substrate; adding PME and the first PME substrate and the second PME substrate at the same time to a reaction vessel; incubating the first PME substrate with PME prior to addition to the second PME substrate; incubating the second PME substrate with PME prior to addition to the first PME substrate; incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the first PME substrate with PME prior to addition to the second PME substrate and
  • this embodiment of the present invention provides a composition comprising a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other; and wherein at least the second PME substrate has been PME pre-treated.
  • PME substrate it is possible to add a PME substrate to a high ester, PME pretreated first PME substrate.
  • PMEs such as, but not limited to, recombinant, plant, fungal and bacterial PMEs
  • it would be possible to exploit different PMEs such as, but not limited to, recombinant, plant, fungal and bacterial PMEs to modify the second PME substrate with a view to providing PME substrates with different functionality in a combination system.
  • the composition may comprise one or more other components, such as one or more suitable food ingredients.
  • suitable food ingredients include any one or more of an acid—such as citric acid—or a sugar—such as sucrose, glucose or invert sugar—or fruit—or other enzymes, preservatives, colourings and other suitable components.
  • composition of the present invention can be used in the preparation of a foodstuff.
  • it may be a starting reagent or an intermediate in the preparation of a foodstuff.
  • composition of the present invention can be the foodstuff itself.
  • the term “foodstuff” can include food for human and/or animal consumption. Typical foodstuffs include jams, marmalades, jellies, dairy products (such as milk or cheese), meat products, poultry products, fish products and bakery products. The foodstuff may even be a beverage.
  • the beverage can be a drinking yoghurt, a fruit juice or a beverage comprising whey protein.
  • PME may be used in conjunction with other types of enzymes.
  • Examples of other types of enzymes include other pectinases, pectin depolymerases, poly-galacturonases, pectate lyases, pectin lyases, rhamno-galacturonases, galactanases, cellulases, hemicellulases, endo- ⁇ -glucanases, arabinases, acetyl esterases, or pectin releasing enzymes, or combinations thereof.
  • the PME is used in conjunction with one or more poly-galacturonases, such as an endo-poly-galacturonase (such as that of WO-A-89/12648, the contents of which are incorporated herein by reference) and/or an exo-poly-galacturonase (such as that of WO-A-94/14966, the contents of which are incorporated herein by reference).
  • poly-galacturonases such as an endo-poly-galacturonase (such as that of WO-A-89/12648, the contents of which are incorporated herein by reference) and/or an exo-poly-galacturonase (such as that of WO-A-94/14966, the contents of which are incorporated herein by reference).
  • This preferred embodiment is of benefit for jam and marmalade manufacture as the resultant treated PME substrates may achieve more controlled calcium sensitivity.
  • teachings of WO-A-97/03574 provide some
  • the host organism can be a prokaryotic or a eukaryotic organism.
  • suitable prokaryotic hosts include E. coli and Bacillus subtilis. Teachings on the transformation of prokaryotic hosts is well documented in the art, for example see Sambrook et al (Molecular Cloning: A Laboratory Manual, 2nd edition, 1989, Cold Spring Harbor Laboratory Press). If a prokaryotic host is used then the gene may need to be suitably modified before transformation—such as by removal of introns.
  • the host organism can be of the genus Aspergillus, such as Aspergillus niger.
  • a transgenic Aspergillus can be prepared by following the teachings of Rambosek, J. and Leach, J. 1987 (Recombinant DNA in filamentous fungi: Progress and Prospects. CRC Crit. Rev. Biotechnol. 6:357-393), Davis R. W. 1994 (Heterologous gene expression and protein secretion in Aspergillus. In: Martinelli S. D., Kinghorn J. R.(Editors) Aspergillus: 50 years on. Progress in industrial microbiology vol 29. Elsevier Amsterdam 1994. pp 525-560), Ballance, D. J.
  • filamentous fungi have been widely used in many types or industry for the production of organic compounds and enzymes.
  • traditional japanese koji and soy fermentations have used Aspergillus sp.
  • Aspergillus niger has been used for production of organic acids particular citric acid and for production of various enzymes for use in industry.
  • filamentous fungi There are two major reasons why filamentous fungi have been so widely used in industry. First filamentous fungi can produce high amounts of extracelluar products, for example enzymes and organic compounds such as antibiotics or organic acids. Second filamentous fungi can grow on low cost substrates such as grains, bran, beet pulp etc. The same reasons have made filamentous fungi attractive organisms as hosts for heterologous expression for recombinant PME.
  • expression constructs are prepared by inserting a requisite nucleotide sequence into a construct designed for expression in filamentous fungi.
  • constructs used for heterologous expression can contain a promoter which is active in fungi.
  • promoters include a fungal promoter for a highly expressed extracelluar enzyme, such as the glucoamylase promoter or the ⁇ -amylase promoter.
  • the nucleotide sequence can be fused to a signal sequence which directs the protein encoded by the nucleotide sequence to be secreted. Usually a signal sequence of fungal origin is used.
  • a terminator active in fungi ends the expression system.
  • nucleotide sequence can be fused to a smaller or a larger part of a fungal gene encoding a stable protein. This can stabilize the protein encoded by the nucleotide sequence.
  • a cleavage site recognized by a specific protease, can be introduced between the fungal protein and the protein encoded by the nucleotide sequence, so the produced fusion protein can be cleaved at this position by the specific protease thus liberating the protein encoded by the nucleotide sequence.
  • a site which is recognized by a KEX-2 like peptidase found in at least some Aspergilli. Such a fusion leads to cleavage in vivo resulting in protection of the expressed product and not a larger fusion protein.
  • proteins can be deposited intracellularly if the nucleotide sequence is not fused to a signal sequence. Such proteins will accumulate in the cytoplasm and will usually not be glycosylated which can be an advantage for some bacterial proteins. If the nucleotide sequence is equipped with a signal sequence the protein will accumulate extracelluarly.
  • heterologous proteins are not very stable when they are secreted into the culture fluid of fungi. Most fungi produce several extracelluar proteases which degrade heterologous proteins. To avoid this problem special fungal strains with reduced protease production have been used as host for heterologous production.
  • filamentous fungi For the transformation of filamentous fungi, several transformation protocols have been developed for many filamentous fungi (Ballance 1991, ibid). Many of them are based on preparation of protoplasts and introduction of DNA into the protoplasts using PEG and Ca 2+ ions. The transformed protoplasts then regenerate and the transformed fungi are selected using various selective markers. Among the markers used for transformation are a number of auxotrophic markers such as argB, trpC, niaD and pyrG, antibiotic resistance markers such as benomyl resistance, hygromycin resistance and phleomycin resistance. A commonly used transformation marker is the amdS gene of A. nidulans which in high copy number allows the fungus to grow with acrylamide as the sole nitrogen source.
  • auxotrophic markers such as argB, trpC, niaD and pyrG
  • antibiotic resistance markers such as benomyl resistance, hygromycin resistance and phleomycin resistance.
  • the transgenic organism can be a yeast.
  • yeast have also been widely used as a vehicle for heterologous gene expression.
  • the species Saccharomyces cerevisiae has a long history of industrial use, including its use for heterologous gene expression.
  • Expression of heterologous genes in Saccharomyces cerevisiae has been reviewed by Goodey et al (1987, Yeast Biotechnology, D R Berry et al, eds, pp 401-429, Allen and Unwin, London) and by King et al (1989, Molecular and Cell Biology of Yeasts, E F Walton and G T Yarronton, eds, pp 107-133, Blackie, Glasgow).
  • Saccharomyces cerevisiae is well suited for heterologous gene expression. First, it is non-pathogenic to humans and it is incapable of producing certain endotoxins. Second, it has a long history of safe use following centuries of commercial exploitation for various purposes. This has led to wide public acceptability. Third, the extensive commercial use and research devoted to the organism has resulted in a wealth of knowledge about the genetics and physiology as well as large-scale fermentation characteristics of Saccharomyces cerevisiae.
  • yeast vectors include integrative vectors, which require recombination with the host genome for their maintenance, and autonomously replicating plasmid vectors.
  • expression constructs are prepared by inserting the nucleotide sequence into a construct designed for expression in yeast.
  • constructs used for heterologous expression have been developed.
  • the constructs contain a promoter active in yeast fused to the nucleotide sequence, usually a promoter of yeast origin, such as the GAL1 promoter, is used.
  • a promoter of yeast origin such as the GAL1 promoter
  • a signal sequence of yeast origin such as the sequence encoding the SUC2 signal peptide, is used.
  • a terminator active in yeast ends the expression system.
  • transgenic Saccharomyces can be prepared by following the teachings of Hinnen et al (1978, Proceedings of the National Academy of Sciences of the USA 75, 1929); Beggs, J D (1978, Nature, London, 275, 104); and Ito, H et al (1983, J Bacteriology 153, 163-168).
  • the transformed yeast cells are selected using various selective markers.
  • markers used for transformation are a number of auxotrophic markers such as LEU2, HIS4 and TRP1, and dominant antibiotic resistance markers such as aminoglycoside antibiotic markers, eg G418.
  • the basic principle in the construction of genetically modified plants is to insert genetic information in the plant genome so as to obtain a stable maintenance of the inserted genetic material.
  • a suitable transformation system for a plant may comprise one vector, but it can comprise two vectors.
  • the vector system is normally referred to as a binary vector system.
  • Binary vector systems are described in further detail in Gynheung An et al. (1980), Binary Vectors, Plant Molecular Biology Manual A 3, 1-19.
  • One extensively employed system for transformation of plant cells with a given promoter or nucleotide sequence or construct is based on the use of a Ti plasmid from Agrobacterium tumefaciens or a Ri plasmid from Agrobacterium rhizogenes as described in An et al. (1986), Plant Physiol. 81, 301-305 and Butcher D. N. et al. (1980), Tissue Culture Methods for Plant Pathologists, eds.: D. S. Ingrams and J. P. Helgeson, 203-208.
  • Ti and Ri plasmids have been constructed which are suitable for the construction of the plant or plant cell constructs described above.
  • a non-limiting example of such a Ti plasmid is pGV3850.
  • the nucleotide sequence or construct should preferably be inserted into the Ti-plasmid between the terminal sequences of the T-DNA or adjacent a T-DNA sequence so as to avoid disruption of the sequences immediately surrounding the T-DNA borders, as at least one of these regions appear to be essential for insertion of modified T-DNA into the plant genome.
  • the vector system is preferably one which contains the sequences necessary to infect the plant (e.g. the vir region) and at least one border part of a T-DNA sequence, the border part being located on the same vector as the genetic construct.
  • the vector system is an Agrobacterium tumefaciens Ti-plasmid or an Agrobacterium rhizogenes Ri-plasmid or a derivative thereof, as these plasmids are well-known and widely employed in the construction of transgenic plants, many vector systems exist which are based on these plasmids or derivatives thereof.
  • the nucleotide sequence may be first constructed in a microorganism in which the vector can replicate and which is easy to manipulate before insertion into the plant.
  • An example of a useful microorganism is E. coli., but other microorganisms having the above properties may be used.
  • a vector of a vector system as defined above has been constructed in E. coli. it is transferred, if necessary, into a suitable Agrobacterium strain, e.g. Agrobacterium tumefaciens.
  • the Ti-plasmid harbouring the nucleotide sequence or construct is thus preferably transferred into a suitable Agrobacterium strain, e.g. A. tumefaciens, so as to obtain an Agrobacterium cell harbouring the nucleotide sequence, which DNA is subsequently transferred into the plant cell to be modified.
  • cloning vectors which contain a replication system in E. coli and a marker which allows a selection of the transformed cells.
  • the vectors contain for example pBR 322, the pUC series, the M13 mp series, pACYC 184 etc.
  • the nucleotide sequence can be introduced into a suitable restriction position in the vector.
  • the contained plasmid is used for the transformation in E. coli.
  • the E. coli cells are cultivated in a suitable nutrient medium and then harvested and lysed.
  • the plasmid is then recovered.
  • sequence analysis there is generally used sequence analysis, restriction analysis, electrophoresis and further biochemical-molecular biological methods. After each manipulation, the used DNA sequence can be restricted and connected with the next DNA sequence. Each sequence can be cloned in the same or different plasmid.
  • a plant to be infected is wounded, e.g. by cutting the plant with a razor or puncturing the plant with a needle or rubbing the plant with an abrasive.
  • the wound is then inoculated with the Agrobacterium.
  • the inoculated plant or plant part is then grown on a suitable culture medium and allowed to develop into mature plants.
  • tissue culturing methods such as by culturing the cells in a suitable culture medium supplied with the necessary growth factors such as amino acids, plant hormones, vitamins, etc.
  • Regeneration of the transformed cells into genetically modified plants may be accomplished using known methods for the regeneration of plants from cell or tissue cultures, for example by selecting transformed shoots using an antibiotic and by subculturing the shoots on a medium containing the appropriate nutrients, plant hormones, etc.
  • compositions suitable for use as a foodstuff or in the preparation of a foodstuff comprises a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other.
  • PME substrates such as pectins obtained from natural plant sources
  • PME substrates are generally in the form of a high ester pectin having a DE of about 70%.
  • Sugar must be added to extracts containing these high ester PME substrates to provide sufficient soluble solids to induce gelling.
  • soluble solids usually a minimum of 55% soluble solids is required. Syneresis tends to occur more frequently when the percentage soluble solids is less than 55%. When syneresis does occur, expensive additives must be used to induce gelling.
  • aqueous system in a solidified gel state having a soluble solids content of less than 50% w/w; wherein the gelling has occurred by use of a high ester PME substrate.
  • the solidified gel state can be determined by the procedure mentioned in the Examples section (infra).
  • the present invention is distinguishable from the teachings of WO-A-94/25575 as that patent application does not disclose or even suggest a composition comprising a PME; a first PME substrate and a second PME substrate; let alone a composition wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. The same is true regarding the teachings of JP-A-63/209533.
  • FIG. 1 which is a bar chart (showing the effect of PPME modification, added pectin and +/ ⁇ calcium).
  • FIG. 2 which is a bar chart (showing the effect of PPME treatment of fruit and pectin (P66)).
  • Calcium sensitivity is measured as the viscosity of a pectin dissolved in a solution with 57.6 mg calcium/g pectin divided by the viscosity of exactly the same amount of pectin in solution, but without added calcium.
  • a calcium insensitive pectin has a CF value of 1.
  • food compositions according to the present invention may comprise one or more other components, such as one or more food ingredients.
  • Typical food ingredients include any one or more of an acid—such as citric acid—or a sugar—such as sucrose, glucose or invert sugar—or fruit, or enzymes.
  • fruit imparts not only taste, colour and structure to the gel, but also pectin, acid and a small amount of solids.
  • fruit dosages are normally from 25% to 60% of the jam.
  • the solids content of ordinary fruit is around 10% Brix, but fruit concentrate, which is typically 65-70% Brix, can also be used.
  • the pH in fruit varies widely, depending on the fruit in question, but most fruits have a pH between 3.0 and 3.5.
  • the pectin content also varies, depending on the fruit in question. For example, redcurrants, blackcurrants and oranges have a high pectin content, and satisfactory gels from these fruits can be obtained by adding only a small amount of extra pectin.
  • the choice of GRINDSTEDTM Pectin depends on the type of jam in question. For example, GRINDSTEDTM Pectin SS 200 is used in jams containing no fruit pieces or jam containing only very small fruit pieces. Fruit separation in such jams is not a problem, and consequently a slow-setting pectin and lower filling temperature can be used.
  • GRINDSTEDTM Pectin RS 400 is used in jams containing large fruit pieces or whole fruit, for instance cherries or strawberries. In jams containing whole fruit it may be difficult to avoid fruit separation, and it is therefore necessary to use a rapid-set pectin such as GRINDSTEDTM Pectin RS 400.
  • pectin type may also depend on the container size in question.
  • the filling temperature is less critical with regard to the stability of pectin, as the jars will cool down relatively quickly after filling and the pectin will not degrade.
  • the cooling time will be very long.
  • the pectin will be especially subject to degradation, and the gel will be weaker at the centre than at the sides. Consequently, a more slow-setting pectin is generally used for large containers, allowing filling at lower temperatures and thereby avoiding degradation of the pectin.
  • HE pectins can require a minimum soluble solids content of 55% before they will gel
  • Sucrose is the sugar normally used, but other sugars may well be used depending on the taste, sweetening effect, crystallisation or structure required. Price may also influence which type of sugar is used.
  • Invert sugar has the same sweetening effect as sucrose, whereas glucose syrup, glucose and sorbitol have a reduced sweetening effect. High fructose corn syrup and fructose will have a greater sweetening effect than sucrose.
  • the structure and strength of the gel as well as the gelling temperature will, to some extent, be influenced by changes in sugar composition.
  • Acid is added for two reasons: 1) partly to reduce the pH level to 3.0-3.2 to obtain a satisfactory gel with the pectin, and 2) partly to enhance the flavour of the fruit.
  • the optimum pH for gelation using the HE pectins depends on the type of pectin and solids content in question.
  • GRINDSTEDTM Pectin RS 400 the optimum pH is approximately 0.2 units higher than for GRINDSTEDTM Pectin SS 200.
  • the acid most commonly used is citric acid, monohydrate, in a 50% w/v solution.
  • Citric acid imparts a relatively strong acid taste to the finished product, whereas malic acid results in a softer but longer-lasting taste.
  • Tartaric acid may result in a slightly bitter taste, and phosphoric acid results in a sweeter taste.
  • Enzymatically treated pectin can prevent syneresis which can often occur in the manufacture of marmalades and jams with low soluble solids contents.
  • This Example may be modified by the addition of or substitution with at least one other suitable food ingredient, and/or by the addition another suitable enzyme (such as a glucanase).
  • another suitable enzyme such as a glucanase
  • Formulation % Soluble Ingredients % Solids Pectin Pre-solution: Enzyme modified pectin 1 (high 0.4-0.7 0.4-0.7 Ca-reactive) Sugar 2.2 2.2 Water 11.0 Fruit Base: PME 2 7-8 Units Fruit with natural pectin* 45.0 4.5 Sugar 42.7 42.7 Water 3.1 Preservatives As required Citric Acid** As required Total ⁇ 105 Evaporation ⁇ 5 Yield 100.0 Final soluble solids 50 ⁇ 50 Final pH 3.2
  • P66 and P60 were produced by plant PME pretreatment of GRINSTEDTTM URS pectin using the following procedure: GRINSTEDTM URS pectin was solubilised in 0.15M NaCl and treated with plant PME for several hours at pH 7.0 at 40° C. After adjusting the pH to 3.0, the solubilised pectin was heated to 100° C. for 5-10 minutes, to inactivate any PME present, after which it was precipitated with isopropanol and dried before use. All three pectin substrates was prepared as an 8% solution and dissolved completely in preheated (80° C.) deionised water using a magnetic stirrer.
  • Pectin gelation can be induced by adding calcium, either as a slurry or as a hydrate, at high temperatures.
  • Ca-citrate C 12 H 10 Ca 3 O 14 4H 2 O
  • Viscosity measurements were performed on a SMS TA-XT2 Texture Analyser (Reciproter) using a cool stored (5° C.) probe (P 25/L), at a speed of 2.0 mm/sec and a penetration of 30%.
  • the sample temperature was 5° C.
  • the peak force in the compression curve shows the gel strength in newton units (N).
  • Syneresis is defined as the inability of a pectin gel to form a solid.
  • a gel was considered to display syneresis if it did not remain intact after inversion of a reaction vessel containing the gel.
  • a gel was considered to display solidification if it remained intact after inversion of a reaction vessel containing the gel.
  • An intact gel displayed a very level surface compared with an non-intact gel.
  • a solidified gel was obtained after combining the P66 pectin substrate with plant PME modified orange mash in the presence but not in the absence of calcium.
  • solidified gels were induced after combining the P60 pectin substrate with plant PME modified mash either in the presence or absence of calcium.
  • FIG. 2 The additive effect of both PME treatment and the presence of calcium on pectin gelation is illustrated in FIG. 2.
  • This figure sets out the percentage relative increase in gel strength (or hardness) observed when a P66 pectin substrate is added to either untreated or PME treated orange mash in the presence and absence of calcium.
  • the actual values for gel strength (N) are shown next to each column and the percentage relative increase in gel strength is shown on the top of each column. Reading the figure from left to right, column one indicates that the untreated orange mash has a low gel strength which, on visual inspection, is in a liquid form.
  • a solidified gel is obtained if a GRINSTEDTM URS pectin substrate and an orange mash preparation are combined and PME treated in the presence of calcium or if a GRINSTEDTM URS pectin substrate and an orange mash preparation are PME pretreated seperately before combination in the presence of calcium.

Abstract

A composition suitable for use as a foodstuff or in the preparation of a foodstuff is described. The composition comprises a pectin methyl esterase (“PME”); a first PME substrate; and a second PME substrate; wherein neither the first PME susbtrate nor the second PME substrate originates in situ from the other.

Description

  • The present invention relates to a composition. In particular, the present invention relates to a composition for use as or in the preparation of a foodstuff. More in particular, the present invention relates to a composition for use as or in the preparation of a foodstuff comprising or made from a pectin or a pectin derivative. [0001]
  • Pectin is an important commodity in today's industry. For example, it can be used in the food industry as a thickening or gelling agent, such as in the preparation of jams. [0002]
  • Pectin is a structural polysaccharide commonly found in the form of protopectin in plant cell walls. The backbone of pectin comprises α-1-4 linked galacturonic acid residues which are interrupted with a small number of 1,2 linked α-L-rhamnose units. In addition, pectin comprises highly branched regions with an almost alternating rhamno-galacturonan chain. These highly branched regions also contain other sugar units (such as D-galactose, L-arabinose and xylose) attached by glycosidic linkages to the C3 or C4 atoms of the rhamnose units or the C2 or C3 atoms of the galacturonic acid units. The long chains of α-1-4 linked galacturonic acid residues are commonly referred to as “smooth” regions, whereas the highly branched regions are commonly referred to as the “hairy regions”. [0003]
  • Some of the carboxyl groups of the galacturonic residues are esterified (e.g. the carboxyl groups are methylated). Typically esterification of the carboxyl groups occurs after polymerisation of the galacturonic acid residues. However, it is extremely rare for all of the carboxyl groups to be esterified (e.g. methylated). Usually, the degree of esterification will vary from 0-90%. If 50% or more of the carboxyl groups are esterified then the resultant pectin is referred to as a “high ester pectin” (“HE pectin” for short) or a “high methoxyl pectin”. If less than 50% of the carboxyl groups are esterified then the resultant pectin is referred to as a “low ester pectin” (“LE pectin” for short) or a “low methoxyl pectin”. If 50% of the carboxyl groups are esterified then the resultant pectin is referred to as a “medium ester pectin” (“ME pectin” for short) or a “medium methoxyl pectin”. If the pectin does not contain any—or only a few—esterified groups it is usually referred to as pectic acid. [0004]
  • The structure of the pectin, in particular the degree of esterification (e.g. methylation), dictates many of the resultant physical and/or chemical properties of the pectin. For example, pectin gelation depends on the chemical nature of the pectin, especially the degree of esterification. In addition, however, pectin gelation also depends on the soluble-solids content, the pH and calcium ion concentration. With respect to the latter, it is believed that the calcium ions form complexes with free carboxyl groups, particularly those on a LE pectin. [0005]
  • Pectic enzymes are classified according to their mode of attack on the galacturonan part of the pectin molecule. A review of some pectic enzymes has been prepared by Pilnik and Voragen (Food Enzymology, Ed.: P. F. Fox; Elsevier; (1991); pp: 303-337). In particular, pectin methylesterases (EC 3.1.1.11), otherwise referred to as PMEs, de-esterify HE pectins to LE pectins or pectic acids. In contrast, and by way of example. pectin depolymerases split the glycosidic linkages between galacturonosyl methylester residues. [0006]
  • In more detail, PME activity produces free carboxyl groups and free methanol. The increase in free carboxyl groups can be easily monitored by automatic titration. In this regard, earlier studies have shown that some PMEs de-esterify pectins in a random manner, in the sense that they de-esterify any of the esterified (e.g. methylated) galacturonic acid residues on one or more than one of the pectin chains. Examples of PMEs that randomly de-esterify pectins may be obtained from fungal sources such as [0007] Aspergillus aculeatus (see WO 94/25575) and Aspergillus japonicus (Ishii et al 1980 J Food Sci 44 pp 611-14). Baron et al (1980 Lebensm. Wiss. M-Technol 13 pp 330-333) apparently have isolated a fungal PME from Aspergillus niger. This fungal PME is reported to have a molecular weight of 39000 D, an isoelectric point of 3.9, an optimum pH of 4.5 and a Km value (mg/ml) of 3.
  • In contrast, some PMEs are known to de-esterify pectins in a block-wise manner, in the sense that it is believed they attack pectins either at non-reducing ends or next to free carboxyl groups and then proceed along the pectin molecules by a single-chain mechanism, thereby creating blocks of un-esterified galacturonic acid units which can be calcium sensitive. Examples of such enzymes that block-wise enzymatically de-esterify pectin are plant PMEs. Up to 12 isoforms of PME have been suggested to exist in citrus (Pilnik W. and Voragen A. G. J. (Food Enzymology (Ed.: P. F. Fox); Elsevier; (1991); pp: 303-337). These isoforms have different properties. [0008]
  • Random or blockwise distribution of free carboxyl groups can be distinguished by high performance ion exchange chromatography (Schols et al Food Hydrocolloids 1989 6 pp 115-121). These tests are often used to check for undesirable, residual PME activity in citrus juices after pasteurisation because residual PME can cause, what is called, “cloud loss” in orange juice in addition to a build up of methanol in the juice. [0009]
  • PME substrates, such as pectins obtained from natural plant sources, are generally in the form of a high ester pectin having a DE of about 70%. Sugar must be added to extracts containing these high ester PME substrates to provide sufficient soluble solids to induce gelling. Usually a minimum of 55% soluble solids is required. Syneresis tends to occur more frequently when the percentage soluble solids is less than 55%. When syneresis does occur, expensive additives must be used to induce gelling. [0010]
  • Versteeg et al (J Food Sci 45 (1980) pp 969-971) apparently have isolated a PME from orange. This plant PME is reported to occur in multiple isoforms of differing properties. Isoform I has a molecular weight of 36000 D, an isoelectric point of 10.0, an optimum pH of 7.6 and a K[0011] m value (mg/ml) of 0.083. Isoform II has a molecular weight of 36200 D, an isoelectric point or 11.0, an optimum pH of 8.8 and a Km value (mg/ml) of 0.0046. Isoform III (HMW-PE) has a molecular weight of 54000 D, an isoelectric point of 10.2, an optimum pH of 8 and a Km value (mg/ml) of 0.041. However, to date there has been very limited sequence data for such PMEs.
  • According to Pilnik and Voragen (ibid), PMEs may be found in a number of other higher plants, such as apple, apricot, avocado, banana, berries, lime, grapefruit, mandarin, cherries, currants, grapes, mango, papaya, passion fruit, peach, pear, plums, beans, carrots, cauliflower, cucumber, leek, onions, pea, potato, radish and tomato. However, likewise, to date there has been very limited sequence data for such PMEs. [0012]
  • A plant PME has been reported in WO-A-97/03574 (the contents of which are incorporated herein by reference). This PME has the following characteristics: a molecular weight of from about 36 kD to about 64 kD; a pH optimum of pH 7-8 when measured with 0.5% lime pectin in 0.15 M NaCl; a temperature optimum of at least 50° C.; a temperature stability in the range of from 10°—at least 40° C.; a K[0013] m value of 0.07%; an activity maximum at levels of about 0.25 M NaCl; an activity maximum at levels of about 0.2 M Na2SO4; and an activity maximum at levels of about 0.3 M NaNO3.
  • Another PME has been reported in WO 97/31102 (the contents of which are incorporated herein by reference). [0014]
  • PMEs have important uses in industry. For example, they can be used in or as sequestering agents for calcium ions. In this regard, and according to Pilnik and Voragen (ibid). cattle feed can be prepared by adding a slurry of calcium hydroxide to citrus peels after juice extraction. After the addition, the high pH and the calcium ions activate any native PME in the peel causing rapid de-esterification of the pectin and calcium pectate coagulation occurs. Bound liquid phase is released and is easily pressed out so that only a fraction of the original water content needs to be removed by expensive thermal drying. The press liquor is then used as animal feed. [0015]
  • As indicated above, a PME has been obtained from [0016] Aspergillus aculeatus (WO 94/25575). Apparently, this PME can be used to improve the firmness of a pectin-containing material, or to de-methylate pectin, or to increase the viscosity of a pectin-containing material.
  • It has also become common to use PME in the preparation of foodstuffs prepared from fruit or vegetable materials containing pectin—such as jams or preservatives. For example, WO-A-94/25575 further reports on the preparation of orange marmalade and tomato paste using PME obtained from [0017] Aspergillus aculeatus.
  • JP-A-63/209553 discloses gels which are obtained by the action of pectin methylesterase, in the presence of a polyvalent metal ion, on a pectic polysaccharide containing as the main component a high-methoxyl poly α-1,4-D-galacturonide chain and a process for their production. [0018]
  • Pilnik and Voragen (ibid) list uses of endogenous PMEs which include their addition to fruit juices to reduce the viscosity of the juice if it contains too much pectin derived from the fruit, their addition as pectinase solutions to the gas bubbles in the albedo of citrus fruit that has been heated to a core temperature of 20° C. to 40° C. in order to facilitate removal of peel and other membrane from intact juice segments (U.S. Pat. No. 4,284,651), and their use in protecting and improving the texture and firmness of several processed fruits and vegetables such as apple (Wiley & Lee 1970 Food Technol 24 1168-70), canned tomatoes (Hsu et al 1965 J Food Sci 30 pp 583-588) and potatoes (Bartolome & Hoff 1972 J Agric Food Chem 20 pp 262-266). [0019]
  • Glahn and Rolin (1994 Food Ingredients Europe, Conf Proceedings pp 252-256) report on the hypothetical application of the industrial “GENU pectin type YM-100” for interacting with sour milk beverages. No details are presented at all on how GENU pectin type YM-100 is prepared. [0020]
  • EP-A-0664300 discloses a chemical fractionation method for preparing calcium sensitive pectin. This calcium sensitive pectin is said to be advantageous for the food industry. [0021]
  • Thus, pectins and de-esterified pectins, in addition to PMEs, have an industrial importance. [0022]
  • We have now found that a benefit derived from use of a PME in the preparation of, for example, a foodstuff will depend to some extent on the quality and quantity and type of the PME used and on the quality and quantity and type of the PME substrates—in particular pectin—that may be present in the material used to prepare the foodstuff. For example, if the substrate is a fruit material or a vegetable material then the amount and/or structure of natural pectin in that substrate will be different for different types of fruit material or vegetable material. This is also borne out by the data presented in WO-A-94/25575, especially FIG. 7 where it is clear to see that its PME system is not ideal. [0023]
  • According to the present invention we have now found that addition of an additional PME substrate enables one to derive even more benefit from the use of a PME in the preparation of, for example, a foodstuff. [0024]
  • In this regard, addition of an additional PME substrate will overcome any problems associated with differing quantities and qualities of PME substrates that may be found in materials used in the preparation of, for example, foodstuffs. [0025]
  • According to a first aspect of the present invention there is provided a composition comprising a pectin methyl esterase (“PME”); a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0026]
  • According to a second aspect of the present invention there is provided a method of preparing a composition, the method comprising forming a mixture of a PME; a first PME substrate, and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0027]
  • According to a third aspect of the present invention there is provided a process comprising adding to a first PME substrate, PME and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0028]
  • According to a fourth aspect of the present invention there is provided a foodstuff comprising or prepared from or by the other aspects of the present invention. [0029]
  • According to a fifth aspect of the present invention there is also provided a composition made from a pectin methyl esterase (“PME”); a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0030]
  • According to a sixth aspect of the present invention there is provided a process of imparting stability to a reaction medium comprising a first PME substrate, the process comprising adding at least PME and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0031]
  • Thus, in its broadest sense, the present invention provides a composition comprising a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0032]
  • With the present invention, neither the first PME substrate nor the second PME substrate originates in situ from the other. The term “neither the first PME substrate nor the second PME substrate originates in situ from the other” means that the first PME substrate does not originate in situ from the second PME substrate and/or the second PME substrate does not originate from the first PME substrate. Hence, with the present invention, the first PME substrate has not been derived in situ from the second PME substrate and vice versa. Thus, for example, the composition of the present invention does not encompass just a quantity of a first PME substrate wherein a portion of that PME substrate has been partially modified by a PME enzyme. In contrast, a second PME substrate must be also present—wherein that second PME substrate has not originated in situ from the first PME substrate. [0033]
  • With the composition of the present invention, there can be present additional, different PME substrate(s). [0034]
  • The PME substrates in or for the composition of the present invention may be obtainable from different sources and/or may be of different chemical composition. [0035]
  • Likewise, with the composition of the present invention, there can be present additional, different PME enzyme(s). [0036]
  • If there is more than one PME present, then the PME enzymes may be obtainable from different sources and/or may be of different composition and/or may have a different reactivity profile (e.g. different pH optimum and/or different temperature optimum). [0037]
  • With the present invention, the PME enzyme may de-esterify the PME substrates in a random manner or in a block-wise manner. If there is more than one PME, then each PME is independently selected from a PME that can de-esterify the PME substrate(s) in a random manner or a PME that can de-esterify the PME substrate(s) in a block-wise manner. [0038]
  • In one preferred embodiment, the (or at least one) PME enzyme de-esterifies the PME substrate(s) in a block-wise manner. [0039]
  • If there is more than one PME, then each PME is independently selected from a PME enzyme that is sensitive to sodium ions (Na-sensitive) or a PME enzyme that is insensitive to sodium ions (Na-insensitive). In one preferred embodiment, the (or at least one) PME enzyme is a PME enzyme that is Na-sensitive. [0040]
  • The PME may be obtainable from natural sources or even obtained from natural sources or it may be chemically synthesised. [0041]
  • For example, the PME may be obtainable from a fungus, such as by way of example a PME of fungal origin (i.e. a PME that has been obtained from a fungus). [0042]
  • Alternatively, the PME may be obtainable from a bacterium, such as by way of example a PME of bacterial origin (i.e. a PME that has been obtained from a bacterium). [0043]
  • Alternatively, the PME may be obtainable from a plant, such as by way of example a PME of plant origin (i.e. a PME that has been obtained from a plant). [0044]
  • In one preferred embodiment, the PME is prepared by use of recombinant DNA techniques. [0045]
  • For example, the PME can be a recombinant PME as disclosed in WO-A-97/03574 or the PME disclosed in either WO-A-94/25575 or WO-A-97/31102 as well as variants, derivatives or homologues of the sequences disclosed in those patent applications. [0046]
  • In one preferred embodiment the PME is the recombinant PME of WO-A-97/03574 (the contents of which are incorporated herein by reference)—such as the PME of SEQ.I.D. No. 1 or SEQ.I.D. No. 2 (which are coded by the nucleotide sequences presented as SEQ.I.D. No. 3 and SEQ.I.D. No. 4 respectively) or a variant, derivative or homologue thereof; and/or the PME of WO-A-94/25575 (the contents of which are incorporated herein by reference), or a variant, derivative or homologue thereof. [0047]
  • The terms “variant”, “homologue” or “fragment” in relation to the recombinant enzyme of the present invention include any substitution of, variation of, modification of, replacement of, deletion of or addition of one (or more) amino acid from or to the sequence providing the resultant amino acid sequence has PME activity, preferably having at least the same activity of a recombinant enzyme comprising any one or more of the sequences shown as SEQ I.D. No.s 1 and 2. In particular, the term “homologue” covers homology with respect to structure and/or function providing the resultant recombinant enzyme has PME activity. With respect to sequence homology (i.e. similarity), preferably there is at least 75%, more preferably at least 85%, more preferably at least 90% homology to the sequences shown in the attached sequence listings. More preferably there is at least 95%, more preferably at least 98%, homology to the sequences shown in the attached sequence listings. [0048]
  • The terms “variant”, “homologue” or “fragment” in relation to the nucleotide sequence coding for the recombinant enzyme of the present invention include any substitution of, variation of, modification of, replacement of, deletion of or addition of one (or more) nucleic acid from or to the sequence providing the resultant nucleotide sequence codes for a recombinant enzyme having PME activity, preferably having at least the same activity of a recombinant enzyme comprising any one or more of the sequences shown as SEQ I.D. No.s 1 and 2. In particular, the term “homologue” covers homology with respect to structure and/or function providing the resultant nucleotide sequence codes for a recombinant enzyme having PME activity. With respect to sequence homology (i.e. similarity), preferably there is at least 75%, more preferably at least 85%, more preferably at least 90% homology. More preferably there is at least 95%, more preferably at least 98%, homology. [0049]
  • The above terms are synonymous with allelic variations of the sequences. [0050]
  • In a preferred embodiment, at least one of the PME substrates is pectin or is a substrate that is derivable from or derived from pectin (eg. a pectin derivative). [0051]
  • The term “derived from pectin” includes derivatised pectin, degraded (such as partially degraded) pectin and modified pectin. An example of a modified pectin is pectin that has been prior treated with an enzyme such as a PME. An example of a pectin derivative is pectin that has been chemically treated—eg. amidated. [0052]
  • Preferably, each of the first PME substrate and the second PME substrate is independently selected from pectin, a substrate that is derivable from pectin, or a substrate that is derived from pectin. [0053]
  • In one preferred embodiment, each of the first PME substrate and the second PME substrate is pectin. [0054]
  • In another preferred embodiment, either the first PME substrate or the second PME substrate is a modified pectin—in particular an enzymatically modified pectin, preferably a PME treated pectin. [0055]
  • In a preferred embodiment, the second PME substrate is such a modified pectin. [0056]
  • In another preferred embodiment, each of the first PME substrate and the second PME substrate is such a modified pectin. [0057]
  • Preferably, the first PME substrate is present within (i.e. in situ) a plant or a plant material. The plant may be a transgenic plant, such as a plant that has been genetically engineered to produce different levels and/or types of pectin. Likewise, the plant material may be obtained from a transgenic plant, such as a plant that has been genetically engineered to produce different levels and/or types of pectin. [0058]
  • The plant or plant material may be or may be derived from a vegetable, a fruit, or other type of pectin containing or producing plant. [0059]
  • Preferably, the plant material is a vegetable material and/or a fruit material. [0060]
  • Preferably, the vegetable material and/or the fruit material is a mash. [0061]
  • The first PME substrate and/or the second PME substrate can be any one or more of a low ester pectin, a medium ester pectin or a high ester pectin. [0062]
  • Preferably, the second PME substrate is a low ester pectin, a medium ester pectin or a high ester pectin. A Protocol for determining the degree of esterification of the PME substrate may be found on page 58 of WO-A-97/03574 (the contents of which are incorporated herein by reference). For ease of reference, this Protocol is recited in the Examples section (infra). [0063]
  • In one preferred embodiment, the second PME substrate is a high ester pectin. [0064]
  • For the present invention the first PME substrate and the second PME substrate are independently selected from a PME substrate that is sensitive to calcium ions (Ca-sensitive) or a PME substrate that is insensitive to calcium ions (Ca-insensitive). A Protocol for determining calcium sensitivity may be found on page 57 of WO-A-97/03574 (the contents of which are incorporated herein by reference). For ease of reference, this Protocol is recited in the Examples section (infra). [0065]
  • In one preferred embodiment, the second PME substrate is Ca-sensitive. [0066]
  • Preferably, the second PME substrate is added to the First PME substrate. Here, the term “added to” includes physically adding the second PME substrate to the first PME substrate and vice versa. [0067]
  • The PME may be added at the same time as the second PME substrate, or before the addition of the second PME substrate or after the addition of the second PME substrate. [0068]
  • Hence, the present invention encompasses at least the following possibilities: adding PME to the first PME substrate and at the same time as the second PME substrate; adding PME to the second PME substrate and at the same time as the first PME substrate; adding the second PME substrate to PME and at the same time as the first PME substrate; adding PME and the first PME substrate and the second PME substrate at the same time to a reaction vessel; incubating the first PME substrate with PME prior to addition to the second PME substrate; incubating the second PME substrate with PME prior to addition to the first PME substrate; incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding a further PME substrate (which may be the same or different as the other PME substrates); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding a further PME substrate (which may be the same or different as the other PME substrates); adding the first PME substrate when incubating with PME to the second PME substrate when incubating with PME (which may be the same or different to the other PME); addition of the first PME substrate after it has been incubated with PME (optionally wherein the reaction has been stopped—such as by application of heat) to the second PME substrate after it has been incubated with PME which may be the same or different to the other PME (optionally wherein the reaction has been stopped—such as by application of heat); as well as any combination thereof. [0069]
  • In a number of embodiments, preferably the present invention comprises any one or more of: adding PME to the first PME substrate and at the same time as the second PME substrate; adding PME to the second PME substrate and at the same time as the first PME substrate; adding the second PME substrate to PME and at the same time as the first PME substrate; adding PME and the first PME substrate and the second PME substrate at the same time to a reaction vessel; incubating the first PME substrate with PME prior to addition to the second PME substrate; incubating the second PME substrate with PME prior to addition to the first PME substrate; incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding more PME (which may be the same or different as the other PME); incubating the first PME substrate with PME prior to addition to the second PME substrate and then adding a further PME substrate (which may be the same or different as the other PME substrates); incubating the second PME substrate with PME prior to addition to the first PME substrate and then adding a further PME substrate (which may be the same or different as the other PME substrates); adding the first PME substrate when incubating with PME to the second PME substrate when incubating with PME (which may be the same or different to the other PME). [0070]
  • Thus, in one embodiment, it is possible to prepare a high ester, PME pretreated second PME substrate which could then be added to a first PME substrate. In this regard, it would be possible to exploit different PMEs (such as, but not limited to, recombinant, plant, fungal and bacterial PMEs) to modify the second PME substrate with a view to providing PME substrates with different functionality in a combination system. [0071]
  • Alternatively expressed, this embodiment of the present invention provides a composition comprising a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other; and wherein at least the second PME substrate has been PME pre-treated. [0072]
  • In another embodiment, it is possible to add a PME substrate to a high ester, PME pretreated first PME substrate. In this regard, it would be possible to exploit different PMEs (such as, but not limited to, recombinant, plant, fungal and bacterial PMEs) to modify the second PME substrate with a view to providing PME substrates with different functionality in a combination system. [0073]
  • In another embodiment, it is possible to prepare a high ester, PME pretreated second PME substrate which could then be added to a high ester, PME pretreated first PME substrate. In this regard, it would be possible to exploit different PMEs (such as, but not limited to, recombinant, plant, fungal and bacterial PMEs) to modify the second PME substrate with a view to providing PME substrates with different functionality in a combination system. [0074]
  • The composition may comprise one or more other components, such as one or more suitable food ingredients. Typical food ingredients include any one or more of an acid—such as citric acid—or a sugar—such as sucrose, glucose or invert sugar—or fruit—or other enzymes, preservatives, colourings and other suitable components. [0075]
  • The composition of the present invention can be used in the preparation of a foodstuff. For example, it may be a starting reagent or an intermediate in the preparation of a foodstuff. [0076]
  • Alternatively, the composition of the present invention can be the foodstuff itself. [0077]
  • The term “foodstuff” can include food for human and/or animal consumption. Typical foodstuffs include jams, marmalades, jellies, dairy products (such as milk or cheese), meat products, poultry products, fish products and bakery products. The foodstuff may even be a beverage. The beverage can be a drinking yoghurt, a fruit juice or a beverage comprising whey protein. [0078]
  • The (or any one or more of each) PME may be used in conjunction with other types of enzymes. [0079]
  • Examples of other types of enzymes include other pectinases, pectin depolymerases, poly-galacturonases, pectate lyases, pectin lyases, rhamno-galacturonases, galactanases, cellulases, hemicellulases, endo-β-glucanases, arabinases, acetyl esterases, or pectin releasing enzymes, or combinations thereof. [0080]
  • These other types of enzymes can be added at the same time as the PME or, alternatively, prior to or after the addition of the PME. [0081]
  • In one preferred embodiment the PME is used in conjunction with one or more poly-galacturonases, such as an endo-poly-galacturonase (such as that of WO-A-89/12648, the contents of which are incorporated herein by reference) and/or an exo-poly-galacturonase (such as that of WO-A-94/14966, the contents of which are incorporated herein by reference). This preferred embodiment is of benefit for jam and marmalade manufacture as the resultant treated PME substrates may achieve more controlled calcium sensitivity. As indicated above, the teachings of WO-A-97/03574 provide some useful teachings on how to prepare a suitable PME for use in the present invention by use of recombinant DNA techniques. Some of these teachings are recited below. [0082]
  • In order to express a recombinant PME, the host organism can be a prokaryotic or a eukaryotic organism. Examples of suitable prokaryotic hosts include [0083] E. coli and Bacillus subtilis. Teachings on the transformation of prokaryotic hosts is well documented in the art, for example see Sambrook et al (Molecular Cloning: A Laboratory Manual, 2nd edition, 1989, Cold Spring Harbor Laboratory Press). If a prokaryotic host is used then the gene may need to be suitably modified before transformation—such as by removal of introns.
  • In one embodiment, the host organism can be of the genus Aspergillus, such as [0084] Aspergillus niger. A transgenic Aspergillus can be prepared by following the teachings of Rambosek, J. and Leach, J. 1987 (Recombinant DNA in filamentous fungi: Progress and Prospects. CRC Crit. Rev. Biotechnol. 6:357-393), Davis R. W. 1994 (Heterologous gene expression and protein secretion in Aspergillus. In: Martinelli S. D., Kinghorn J. R.(Editors) Aspergillus: 50 years on. Progress in industrial microbiology vol 29. Elsevier Amsterdam 1994. pp 525-560), Ballance, D. J. 1991 (Transformation systems for Filamentous Fungi and an Overview of Fungal Gene structure. In: Leong, S. A., Berka R. M. (Editors) Molecular Industrial Mycology. Systems and Applications for Filamentous Fungi. Marcel Dekker Inc. New York 1991. pp 1-29) and Turner G. 1994 (Vectors for genetic manipulation. In: Martinelli S. D., Kinghorn J. R. (Editors) Aspergillus: 50 years on. Progress in industrial microbiology vol 29. Elsevier Amsterdam 1994. pp. 641-666). However, the following commentary provides a summary of those teachings for producing transgenic Aspergillus.
  • For almost a century, filamentous fungi have been widely used in many types or industry for the production of organic compounds and enzymes. For example, traditional japanese koji and soy fermentations have used Aspergillus sp. Also, in this century [0085] Aspergillus niger has been used for production of organic acids particular citric acid and for production of various enzymes for use in industry.
  • There are two major reasons why filamentous fungi have been so widely used in industry. First filamentous fungi can produce high amounts of extracelluar products, for example enzymes and organic compounds such as antibiotics or organic acids. Second filamentous fungi can grow on low cost substrates such as grains, bran, beet pulp etc. The same reasons have made filamentous fungi attractive organisms as hosts for heterologous expression for recombinant PME. [0086]
  • In order to prepare the transgenic Aspergillus, expression constructs are prepared by inserting a requisite nucleotide sequence into a construct designed for expression in filamentous fungi. [0087]
  • Several types of constructs used for heterologous expression have been developed. These constructs can contain a promoter which is active in fungi. Examples of promoters include a fungal promoter for a highly expressed extracelluar enzyme, such as the glucoamylase promoter or the α-amylase promoter. The nucleotide sequence can be fused to a signal sequence which directs the protein encoded by the nucleotide sequence to be secreted. Usually a signal sequence of fungal origin is used. A terminator active in fungi ends the expression system. [0088]
  • Another type of expression system has been developed in fungi where the nucleotide sequence can be fused to a smaller or a larger part of a fungal gene encoding a stable protein. This can stabilize the protein encoded by the nucleotide sequence. In such a system a cleavage site, recognized by a specific protease, can be introduced between the fungal protein and the protein encoded by the nucleotide sequence, so the produced fusion protein can be cleaved at this position by the specific protease thus liberating the protein encoded by the nucleotide sequence. By way of example, one can introduce a site which is recognized by a KEX-2 like peptidase found in at least some Aspergilli. Such a fusion leads to cleavage in vivo resulting in protection of the expressed product and not a larger fusion protein. [0089]
  • Heterologous expression in Aspergillus has been reported for several genes coding for bacterial, fungal, vertebrate and plant proteins. The proteins can be deposited intracellularly if the nucleotide sequence is not fused to a signal sequence. Such proteins will accumulate in the cytoplasm and will usually not be glycosylated which can be an advantage for some bacterial proteins. If the nucleotide sequence is equipped with a signal sequence the protein will accumulate extracelluarly. [0090]
  • With regard to product stability and host strain modifications, some heterologous proteins are not very stable when they are secreted into the culture fluid of fungi. Most fungi produce several extracelluar proteases which degrade heterologous proteins. To avoid this problem special fungal strains with reduced protease production have been used as host for heterologous production. [0091]
  • For the transformation of filamentous fungi, several transformation protocols have been developed for many filamentous fungi (Ballance 1991, ibid). Many of them are based on preparation of protoplasts and introduction of DNA into the protoplasts using PEG and Ca[0092] 2+ ions. The transformed protoplasts then regenerate and the transformed fungi are selected using various selective markers. Among the markers used for transformation are a number of auxotrophic markers such as argB, trpC, niaD and pyrG, antibiotic resistance markers such as benomyl resistance, hygromycin resistance and phleomycin resistance. A commonly used transformation marker is the amdS gene of A. nidulans which in high copy number allows the fungus to grow with acrylamide as the sole nitrogen source.
  • In another embodiment the transgenic organism can be a yeast. In this regard, yeast have also been widely used as a vehicle for heterologous gene expression. The species [0093] Saccharomyces cerevisiae has a long history of industrial use, including its use for heterologous gene expression. Expression of heterologous genes in Saccharomyces cerevisiae has been reviewed by Goodey et al (1987, Yeast Biotechnology, D R Berry et al, eds, pp 401-429, Allen and Unwin, London) and by King et al (1989, Molecular and Cell Biology of Yeasts, E F Walton and G T Yarronton, eds, pp 107-133, Blackie, Glasgow).
  • For several reasons [0094] Saccharomyces cerevisiae is well suited for heterologous gene expression. First, it is non-pathogenic to humans and it is incapable of producing certain endotoxins. Second, it has a long history of safe use following centuries of commercial exploitation for various purposes. This has led to wide public acceptability. Third, the extensive commercial use and research devoted to the organism has resulted in a wealth of knowledge about the genetics and physiology as well as large-scale fermentation characteristics of Saccharomyces cerevisiae.
  • A review of the principles of heterologous gene expression in [0095] Saccharomyces cerevisiae and secretion of gene products is given by E Hinchcliffe E Kenny (1993, “Yeast as a vehicle for the expression of heterologous genes”, Yeasts, Vol 5, Anthony H Rose and J Stuart Harrison, eds, 2nd edition, Academic Press Ltd.).
  • Several types of yeast vectors are available, including integrative vectors, which require recombination with the host genome for their maintenance, and autonomously replicating plasmid vectors. [0096]
  • In order to prepare the transgenic Saccharomyces, expression constructs are prepared by inserting the nucleotide sequence into a construct designed for expression in yeast. Several types of constructs used for heterologous expression have been developed. The constructs contain a promoter active in yeast fused to the nucleotide sequence, usually a promoter of yeast origin, such as the GAL1 promoter, is used. Usually a signal sequence of yeast origin, such as the sequence encoding the SUC2 signal peptide, is used. A terminator active in yeast ends the expression system. [0097]
  • For the transformation of yeast several transformation protocols have been developed. For example, a transgenic Saccharomyces can be prepared by following the teachings of Hinnen et al (1978, Proceedings of the National Academy of Sciences of the USA 75, 1929); Beggs, J D (1978, Nature, London, 275, 104); and Ito, H et al (1983, J Bacteriology 153, 163-168). [0098]
  • The transformed yeast cells are selected using various selective markers. Among the markers used for transformation are a number of auxotrophic markers such as LEU2, HIS4 and TRP1, and dominant antibiotic resistance markers such as aminoglycoside antibiotic markers, eg G418. [0099]
  • Another host organism is a plant. In this regard, the art is replete with references for preparing transgenic plants. Two documents that provide some background commentary on the types of techniques that may be employed to prepare transgenic plants are EP-B-0470145 and CA-A-2006454—some of which commentary is presented below. [0100]
  • The basic principle in the construction of genetically modified plants is to insert genetic information in the plant genome so as to obtain a stable maintenance of the inserted genetic material. [0101]
  • Several techniques exist for inserting the genetic information, the two main principles being direct introduction of the genetic information and indirect introduction of the genetic information by use of a vector system. A review of the general techniques may be found in articles by Potrykus (Annu Rev Plant Physiol Plant Mol Biol [1991] 42:205-225) and Christou (Agro-Food-Industry Hi-Tech Mar./Apr. 17-27, 1994). [0102]
  • A suitable transformation system for a plant may comprise one vector, but it can comprise two vectors. In the case of two vectors, the vector system is normally referred to as a binary vector system. Binary vector systems are described in further detail in Gynheung An et al. (1980), Binary Vectors, [0103] Plant Molecular Biology Manual A3, 1-19.
  • One extensively employed system for transformation of plant cells with a given promoter or nucleotide sequence or construct is based on the use of a Ti plasmid from [0104] Agrobacterium tumefaciens or a Ri plasmid from Agrobacterium rhizogenes as described in An et al. (1986), Plant Physiol. 81, 301-305 and Butcher D. N. et al. (1980), Tissue Culture Methods for Plant Pathologists, eds.: D. S. Ingrams and J. P. Helgeson, 203-208.
  • Several different Ti and Ri plasmids have been constructed which are suitable for the construction of the plant or plant cell constructs described above. A non-limiting example of such a Ti plasmid is pGV3850. [0105]
  • The nucleotide sequence or construct should preferably be inserted into the Ti-plasmid between the terminal sequences of the T-DNA or adjacent a T-DNA sequence so as to avoid disruption of the sequences immediately surrounding the T-DNA borders, as at least one of these regions appear to be essential for insertion of modified T-DNA into the plant genome. [0106]
  • As will be understood from the above explanation, if the organism is a plant, then the vector system is preferably one which contains the sequences necessary to infect the plant (e.g. the vir region) and at least one border part of a T-DNA sequence, the border part being located on the same vector as the genetic construct. Preferably, the vector system is an [0107] Agrobacterium tumefaciens Ti-plasmid or an Agrobacterium rhizogenes Ri-plasmid or a derivative thereof, as these plasmids are well-known and widely employed in the construction of transgenic plants, many vector systems exist which are based on these plasmids or derivatives thereof.
  • In the construction of a transgenic plant the nucleotide sequence may be first constructed in a microorganism in which the vector can replicate and which is easy to manipulate before insertion into the plant. An example of a useful microorganism is [0108] E. coli., but other microorganisms having the above properties may be used. When a vector of a vector system as defined above has been constructed in E. coli. it is transferred, if necessary, into a suitable Agrobacterium strain, e.g. Agrobacterium tumefaciens. The Ti-plasmid harbouring the nucleotide sequence or construct is thus preferably transferred into a suitable Agrobacterium strain, e.g. A. tumefaciens, so as to obtain an Agrobacterium cell harbouring the nucleotide sequence, which DNA is subsequently transferred into the plant cell to be modified.
  • As reported in CA-A-2006454, a large amount of cloning vectors are available which contain a replication system in [0109] E. coli and a marker which allows a selection of the transformed cells. The vectors contain for example pBR 322, the pUC series, the M13 mp series, pACYC 184 etc.
  • In this way, the nucleotide sequence can be introduced into a suitable restriction position in the vector. The contained plasmid is used for the transformation in [0110] E. coli. The E. coli cells are cultivated in a suitable nutrient medium and then harvested and lysed. The plasmid is then recovered. As a method of analysis there is generally used sequence analysis, restriction analysis, electrophoresis and further biochemical-molecular biological methods. After each manipulation, the used DNA sequence can be restricted and connected with the next DNA sequence. Each sequence can be cloned in the same or different plasmid.
  • After each introduction method of the desired promoter or construct or nucleotide sequence in the plants the presence and/or insertion of further DNA sequences may be necessary. If, for example, for the transformation the Ti- or Ri-plasmid of the plant cells is used, at least the right boundary and often however the right and the left boundary of the Ti- and Ri-plasmid T-DNA, as flanking areas of the introduced genes, can be connected. The use of T-DNA for the transformation of plant cells has been intensively studied and is described in EP-A-120516: Hoekema, in: The Binary Plant Vector System Offset-drukkerij Kanters B. B., Alblasserdam, 1985, Chapter V; Fraley, et al., Crit. Rev. Plant Sci., 4:146; and An et al., EMBO J. (1985) 4:277-284. [0111]
  • Direct infection of plant tissues by Agrobacterium is a simple technique which has been widely employed and which is described in Butcher D. N. et al. (1980), [0112] Tissue Culture Methods for Plant Pathologists, eds.: D. S. Ingrams and J. P. Helgeson, 203-208. For further teachings on this topic see Potrykus (Annu Rev Plant Physiol Plant Mol Biol [1991] 42:205-225) and Christou (Agro-Food-Industry Hi-Tech Mar./Apr. 17-27, 1994). With this technique, infection of a plant may be done on a certain part or tissue of the plant, i.e. on a part of a leaf, a root, a stem or another part of the plant.
  • Typically, with direct infection of plant tissues by Agrobacterium carrying the promoter and/or the GOI, a plant to be infected is wounded, e.g. by cutting the plant with a razor or puncturing the plant with a needle or rubbing the plant with an abrasive. The wound is then inoculated with the Agrobacterium. The inoculated plant or plant part is then grown on a suitable culture medium and allowed to develop into mature plants. [0113]
  • When plant cells are constructed, these cells may be grown and maintained in accordance with well-known tissue culturing methods such as by culturing the cells in a suitable culture medium supplied with the necessary growth factors such as amino acids, plant hormones, vitamins, etc. Regeneration of the transformed cells into genetically modified plants may be accomplished using known methods for the regeneration of plants from cell or tissue cultures, for example by selecting transformed shoots using an antibiotic and by subculturing the shoots on a medium containing the appropriate nutrients, plant hormones, etc. [0114]
  • Further teachings on plant transformation may be found in EP-A-0449375. [0115]
  • In summation, a composition suitable for use as a foodstuff or in the preparation of a foodstuff is described. The composition comprises a PME; a first PME substrate; and a second PME substrate; wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. [0116]
  • As indicated above, PME substrates, such as pectins obtained from natural plant sources, are generally in the form of a high ester pectin having a DE of about 70%. Sugar must be added to extracts containing these high ester PME substrates to provide sufficient soluble solids to induce gelling. Usually a minimum of 55% soluble solids is required. Syneresis tends to occur more frequently when the percentage soluble solids is less than 55%. When syneresis does occur, expensive additives must be used to induce gelling. [0117]
  • With the present invention we have found that it is surprisingly possible to induce gelation of an extract containing a high ester PME substrate by adding a second high ester PME substrate. The increased gelling capability of these combined high ester PME substrates at levels of soluble solids which are less than 50% is completely unexpected. The prior art has always taught that high ester pectins typically require a minimum soluble solid content of 55% before gelling can occur. [0118]
  • Thus, in accordance with the broadest aspect of this preferred embodiment of the present invention we provide an aqueous system in a solidified gel state having a soluble solids content of less than 50% w/w; wherein the gelling has occurred by use of a high ester PME substrate. In this aspect, the solidified gel state can be determined by the procedure mentioned in the Examples section (infra). [0119]
  • The present invention is distinguishable from the teachings of WO-A-94/25575 as that patent application does not disclose or even suggest a composition comprising a PME; a first PME substrate and a second PME substrate; let alone a composition wherein neither the first PME substrate nor the second PME substrate originates in situ from the other. The same is true regarding the teachings of JP-A-63/209533. [0120]
  • It is also to be noted that the teachings on page 12 (lines 6-14) of WO-A-94/25575 even point away from the present invention. In this regard, the term “vegetable or fruit based products” as used on lines 7 and 8 of WO-A-94/25575 does not explicitly disclose a PME substrate. Moreover, the subsequent sentence “Alternatively (with our emphasis), the natural content of pectin may be demethylated by use of the enzyme . . . ” on lines 12 to 14 of WO-A-94/25575 clearly points out that the reaction medium envisaged by WO-A-94/25575 only involves one PME substrate, and not at least two PME substrates as is found in the present invention.[0121]
  • The present invention will now be described only by way of example in which reference is made to the accompanying figures: [0122]
  • FIG. 1 which is a bar chart (showing the effect of PPME modification, added pectin and +/− calcium). [0123]
  • FIG. 2 which is a bar chart (showing the effect of PPME treatment of fruit and pectin (P66)). [0124]
  • PROTOCOLS PROTOCOL I CALCIUM SENSITIVITY INDEX (CF)
  • Calcium sensitivity is measured as the viscosity of a pectin dissolved in a solution with 57.6 mg calcium/g pectin divided by the viscosity of exactly the same amount of pectin in solution, but without added calcium. A calcium insensitive pectin has a CF value of 1. [0125]
  • 4.2 g pectin sample is dissolved in 550 ml hot water with efficient stirring. The solution is cooled to about 20° C. and the pH adjusted to 1.5 with 1N HCl. The pectin solution is adjusted to 700 ml with water and stirred. 145 g of this solution is measured individually into 4 viscosity glasses. 10 ml water is added to two of the glasses (double determinations) and 10 ml of a 250 mM CaCl[0126] 2 solution is added to the other two glasses under stirring.
  • 50 ml of an acetate buffer (0.5 M, pH about 4.6) is added to all four viscosity glasses under efficient magnetic stirring, thereby bringing the pH of the pectin solution up over pH 4.0. The magnets are removed and the glasses left overnight at 20° C. The viscosities are measured the next day with a Brookfield viscometer. The calcium sensitivity index is calculated as follows: [0127] CF = Viscosity of a solution with 57.6 mg Ca 2 + / g pectin Viscosity of a solution with 0.0 mg Ca 2 + / g pectin
    Figure US20020015758A1-20020207-M00001
  • PROTOCOL II DEGREE OF ESTERIFICATION (%DE)
  • To 50 ml of a 60% isopropanol and a 5% HCl solution is added 2.5 g pectin sample and stirred for 10 min. The pectin solution is filtered through a glass filter and washed with 15 ml 60% isopropanol/5% HCl solution 6 times followed by further washes with 60% isopropanol until the filtrate is free of chlorides. The filtrate is dried overnight at 80° C. [0128]
  • 20.0 ml 0.5 N NaOH and 20.0 ml 0.5 N HCl is combined in a conical flask and 2 drops of phenolphtalein is added. This is titrated with 0.1 N NaOH until a permanent colour change is obtained. The 0.5 N HCl should be slightly stronger than the 0.5N NaOH. The added volume of 0.1 N NaOH is noted as V[0129] 0.
  • 0.5 g of the dried pectin sample (the filtrate) is measured into a conical flask and the sample is moistened with 96% ethanol. 100 ml of recently boiled and cooled destilled water is added and the resulting solution stirred until the pectin is completely dissolved. Then 5 drops of phenolphtalein are added and the solution titrated with 0.1 N NaOH (until a change in colour and pH is 8.5). The amount of 0.1 N NaOH used here is noted as V[0130] I. 20.0 ml of 0.5 N NaOH is added and the flask shaken vigously, and then allowed to stand for 15 min. 20.0 ml of 0.5 N HCl is added and the flask is shaken until the pink colour disappears. 3 drops of phenolphtalein are then added and then the resultant solution is titrated with 0.1 N NaOH. The volume 0.1 N NaOH used is noted as V2.
  • The degree of esterification (% DE: % of total carboxy groups) is calculated as follows: [0131] % DE = V 2 - V 0 V 1 + ( V 2 - V 0 )
    Figure US20020015758A1-20020207-M00002
  • FOOD PREPARATIONS [0132]
  • Introduction [0133]
  • By way of introduction, food compositions according to the present invention may comprise one or more other components, such as one or more food ingredients. Typical food ingredients include any one or more of an acid—such as citric acid—or a sugar—such as sucrose, glucose or invert sugar—or fruit, or enzymes. [0134]
  • For example, fruit imparts not only taste, colour and structure to the gel, but also pectin, acid and a small amount of solids. Depending on the level of natural flavour and colour in the fruit, fruit dosages are normally from 25% to 60% of the jam. The solids content of ordinary fruit is around 10% Brix, but fruit concentrate, which is typically 65-70% Brix, can also be used. The pH in fruit varies widely, depending on the fruit in question, but most fruits have a pH between 3.0 and 3.5. [0135]
  • The pectin content also varies, depending on the fruit in question. For example, redcurrants, blackcurrants and oranges have a high pectin content, and satisfactory gels from these fruits can be obtained by adding only a small amount of extra pectin. The choice of GRINDSTED™ Pectin depends on the type of jam in question. For example, GRINDSTED[0136] ™ Pectin SS 200 is used in jams containing no fruit pieces or jam containing only very small fruit pieces. Fruit separation in such jams is not a problem, and consequently a slow-setting pectin and lower filling temperature can be used. GRINDSTED™ Pectin RS 400 is used in jams containing large fruit pieces or whole fruit, for instance cherries or strawberries. In jams containing whole fruit it may be difficult to avoid fruit separation, and it is therefore necessary to use a rapid-set pectin such as GRINDSTED™ Pectin RS 400.
  • The choice of pectin type may also depend on the container size in question. When standard jars are used, the filling temperature is less critical with regard to the stability of pectin, as the jars will cool down relatively quickly after filling and the pectin will not degrade. However, if the jam is filled into large containers, eg 500 or 1,000 kg, the cooling time will be very long. In the centre of such a large container the pectin will be especially subject to degradation, and the gel will be weaker at the centre than at the sides. Consequently, a more slow-setting pectin is generally used for large containers, allowing filling at lower temperatures and thereby avoiding degradation of the pectin. [0137]
  • Sugar is added to jam for various reasons, such as: [0138]
  • 1. To provide soluble solids—HE pectins can require a minimum soluble solids content of 55% before they will gel [0139]
  • 2. To provide sweetness [0140]
  • 3. To provide increased physical, chemical and microbiological stability [0141]
  • 4. To provide an improved mouthfeel [0142]
  • 5. To provide improved colour and gloss [0143]
  • Sucrose is the sugar normally used, but other sugars may well be used depending on the taste, sweetening effect, crystallisation or structure required. Price may also influence which type of sugar is used. [0144]
  • Invert sugar has the same sweetening effect as sucrose, whereas glucose syrup, glucose and sorbitol have a reduced sweetening effect. High fructose corn syrup and fructose will have a greater sweetening effect than sucrose. [0145]
  • The structure and strength of the gel as well as the gelling temperature will, to some extent, be influenced by changes in sugar composition. [0146]
  • Acid is added for two reasons: 1) partly to reduce the pH level to 3.0-3.2 to obtain a satisfactory gel with the pectin, and 2) partly to enhance the flavour of the fruit. The optimum pH for gelation using the HE pectins depends on the type of pectin and solids content in question. [0147]
  • If GRINDSTED[0148] ™ Pectin SS 200 is used in jam with 65-68% Brix, the optimum pH is 3.0-3.2.
  • If the solids content is higher than this, the optimum pH is 3.1-3.3. [0149]
  • Conversely, if the solids content is lower the optimum pH is 2.8-3.0. [0150]
  • If GRINDSTED™ Pectin RS 400 is used, the optimum pH is approximately 0.2 units higher than for GRINDSTED[0151] ™ Pectin SS 200.
  • The acid most commonly used is citric acid, monohydrate, in a 50% w/v solution. [0152]
  • Other acids (such as malic acid, tartaric acid or phosphoric acid) may be used but must always be in solution. [0153]
  • The choice of acid depends on legislation, price, and the tartness of sweetness required in the finished product. [0154]
  • Citric acid imparts a relatively strong acid taste to the finished product, whereas malic acid results in a softer but longer-lasting taste. [0155]
  • Tartaric acid may result in a slightly bitter taste, and phosphoric acid results in a sweeter taste. [0156]
  • Enzymatically treated pectin can prevent syneresis which can often occur in the manufacture of marmalades and jams with low soluble solids contents. [0157]
  • Low Sugar Jam and Marmalade With 25% SS [0158]
  • Formulation [0159]
    % Soluble
    Ingredients % Solids
    Pectin Pre-solution:
    Enzyme modified pectin1 (high 0.6-0.8 0.6-0.8
    Ca-reactive)
    Sugar 3.6 3.6
    Water 18.0
    Fruit Base:
    PME2 7-8 Units
    Fruit with natural pectin* 45.0 4.5
    Sugar 15.9 15.9
    Water 21.1
    Preservatives As required
    Citric Acid** As required
    Total ˜104
    Evaporation ˜4
    Yield 100.0
    Final soluble solids 25 ˜25
    Final pH 3.2
  • Procedure [0160]
  • Pectin Solution Preparation: [0161]
  • 1. Dry mix enzyme modified pectin and sugar [0162]
  • 2. Dissolve the pectin-sugar mix in hot water (80° C.), agitating well [0163]
  • Jam: [0164]
  • 1. Fruit, sugar and water are mixed [0165]
  • 2. The fruit mix is given a short boil and cooled to 40° C. [0166]
  • 3. After cooling to 40° C., PME solution is added [0167]
  • 4. Reaction time for the fruit mix is one hour [0168]
  • 5. The fruit mix is heated to 85° C. for a few minutes, and the jam is evaporated to the desired SS content [0169]
  • 6. The pectin solution is added [0170]
  • 7. Preservatives are added and pH is adjusted [0171]
  • 8. The jam is cooled to filling temperature, filled and cooled to room temperature [0172]
  • This Example may be modified by the addition of or substitution with at least one other suitable food ingredient, and/or by the addition another suitable enzyme (such as a glucanase). [0173]
  • Low Sugar Jam and Marmalade With 50% SS [0174]
  • Formulation [0175]
    % Soluble
    Ingredients % Solids
    Pectin Pre-solution:
    Enzyme modified pectin1 (high 0.4-0.7 0.4-0.7
    Ca-reactive)
    Sugar 2.2 2.2
    Water 11.0
    Fruit Base:
    PME2 7-8 Units
    Fruit with natural pectin* 45.0 4.5
    Sugar 42.7 42.7
    Water 3.1
    Preservatives As required
    Citric Acid** As required
    Total ˜105
    Evaporation ˜5
    Yield 100.0
    Final soluble solids 50 ˜50
    Final pH 3.2
  • Procedure [0176]
  • Pectin Solution Preparation: [0177]
  • 1. Dry mix enzyme modified pectin and sugar [0178]
  • 2. Dissolve the pectin-sugar mix in hot water (80° C.), agitating well [0179]
  • Jam: [0180]
  • 1. Fruit and water are mixed [0181]
  • 2. The fruit mix is given a short boil and cooled to 40° C. [0182]
  • 3. After cooling to 40° C., PME solution is added [0183]
  • 4. Reaction time for the fruit mix is one hour [0184]
  • 5. The fruit mix is heated to 85° C. for a few minutes [0185]
  • 6. The remaining sugar and the pectin solution is added, and the jam is evaporated to the desired SS content [0186]
  • 7. The jam is cooled to filling temperature, filled and cooled to room temperature [0187]
  • This Example may be modified by the addition of or substitution with at least one other suitable food ingredient, and/or by the addition another suitable enzyme (such as a glucanase). [0188]
  • Modifications to the present invention will be apparent to those skilled in the art. For example, and as indicated in the above examples, additional examples would include application of both PME and glucanase to obtain a pectin with a lower degree of esterification (eg a slow-set pectin). [0189]
  • Preparation of Plant PME Modified Orange Mash [0190]
  • Stage I [0191]
  • Orange pieces were homogenised in a blender and boiled for 15 minutes to inactivate any endogenous enzymes. After freeze/thawing, 20% (w/w) sugar was added and the orange mash was diluted 1:1 with preheated (95-100° C.) deionised water. The mash was transfered to glass beakers, its pH and temperature were adjusted to 7.0 (using 10% NaOH) and 40° C. respectively. [0192]
  • Purified plant PME (300 μmol/min/ml), at a concentration of (113 μl/200 g orange mash), was incubated with the mash at 40° C. for 15 minutes after which the pH was adjusted to 3.2 (+/−0.6) using citric acid (50% w/v). To inactivate the added plant PME, the mash was heat treated at 85° C. for 3 minutes. While plant PME activity typically requires the addition of NaCl for activity, this preparation of enzymatically modified orange mash did not require any exogenously added NaCl as sufficient endogenous NaCl (24 ppm) was present to ensure PME activity. [0193]
  • The plant PME treated mash (approximately 90 g) was stored in crystallisation dishes (diameter: 60 mm, height: 35 mm) at 5° C. All pectin gelation measurements were performed within three days of processing and yielded reproducible results. [0194]
  • Stage II—Selection, Preparation and Addition of Pectin Substrates [0195]
  • Selection: Three pectin substrates were selected for use. All three substrates, GRINDSTED™ pectin SS200, P66 and P60 substrates had a high degree of esterification (%DE). These were 65%, 66% and 60% respectively. Both P60 and P66 were produced by plant PME pretreatment of GRINDSTED™ Ultra Rapid Set (URS) pectin whereas the GRINSTED™ pectin SS200 was untreated. Two of the three substrates. P60 and P66 were calcium sensitive whereas GRINSTED™ pectin SS200 was calcium insensitive. Only one of the substrates, GRINSTED™ pectin SS200, was commercially available. [0196]
  • Preparation: P66 and P60 were produced by plant PME pretreatment of GRINSTEDT™ URS pectin using the following procedure: GRINSTED™ URS pectin was solubilised in 0.15M NaCl and treated with plant PME for several hours at pH 7.0 at 40° C. After adjusting the pH to 3.0, the solubilised pectin was heated to 100° C. for 5-10 minutes, to inactivate any PME present, after which it was precipitated with isopropanol and dried before use. All three pectin substrates was prepared as an 8% solution and dissolved completely in preheated (80° C.) deionised water using a magnetic stirrer. [0197]
  • Addition: The addition of each pectin substrate to the plant PME enzymatically modified mash was performed using a high speed magnetic stirrer to ensure a homogeneous solution. [0198]
  • Stage III—Preparation and Addition of Calcium Citrate [0199]
  • Pectin gelation can be induced by adding calcium, either as a slurry or as a hydrate, at high temperatures. Ca-citrate (C[0200] 12H10Ca3O144H2O) was added at a final concentration of 5 mM to the mixture.
  • Stage IV—Measurement of Gel Strength [0201]
  • The degree of pectin gelation/gel strength was determined by compression tests using a texture analyser. The methodology is described in “The Chemistry and Technology of Pectin” Ed. Reginald H Walker; Academic Press; (1991) p 240 (the contents of which are incorporated herein by reference). [0202]
  • Viscosity measurements, induced by compression, were performed on a SMS TA-XT2 Texture Analyser (Reciproter) using a cool stored (5° C.) probe (P 25/L), at a speed of 2.0 mm/sec and a penetration of 30%. The sample temperature was 5° C. The peak force in the compression curve shows the gel strength in newton units (N). [0203]
  • Stage V—Tests for Syneresis and Solidification [0204]
  • Syneresis is defined as the inability of a pectin gel to form a solid. A gel was considered to display syneresis if it did not remain intact after inversion of a reaction vessel containing the gel. A gel was considered to display solidification if it remained intact after inversion of a reaction vessel containing the gel. An intact gel displayed a very level surface compared with an non-intact gel. [0205]
  • RESULTS
  • Characterisation of Plant PME Treated Orange Mash [0206]
  • Plant PME treatment of orange mash resulted in a high ester pectin with an average degree of esterification (%DE) of 55.2% (%DE was determined according to Protocol II). [0207]
    TABLE I
    Effect of Calcium (0.096/g Ca-citrate/100/g orange mash) and/or
    plant PME treatment on orange mash gel strength.
    Plant PME
    Treatment Ca-Citrate (5 mM) Gel Strength (N) Solidified Gel Y/N
    0.175 No
    + 0.234 No
    + 0.227 No
    + + 0.226 No
  • The gel strength of extracted orange mash was slightly modified by either treatment with plant PME or the addition of calcium (Table I). However, the sequential treatment of orange mash with plant PME followed by the addition of calcium had no synergistic effect on the gel strength achieved. The visual inspection of the gels indicated that were all in liquid form. [0208]
  • These results demonstrate that, although plant PME treatment of orange mash resulted in a more homogeneous product in terms of its degree of esterification (%DE of 55.2%) and its responsiveness to low levels of endogenous calcium, the enzymatically modified mash did not respond to exogenously added calcium in terms of calcium gelation or increased gel strength. [0209]
  • These results also demonstrate that the reaction of plant PME treated orange mash, with either endogenous or exogenously added calcium ions, is not sufficient for a satisfactory increase in gel strength to take place. [0210]
  • The addition of a second pectin substrate, such as P66 or P60, to the plant PME modified mash, either in the presence or absence of calcium, induced substantial increases in gel strength compared with the untreated orange mash control (Table II: FIG. 1). Specifically, both P66 and P60 pectin substrates induced 3-fold and 5-fold increases in gel strength respectively, after addition of each substrate to the plant PME modified orange mash, in the presence of calcium. The fold increase in gel strength is slightly less pronounced for both pectin substrates in the absence of calcium in the reaction mix. [0211]
  • The addition of the GRINDSTED™ pectin SS200 substrate to the plant PME modified mash failed to induce a fold increase in gel strength as the GRINSTED™ pectin SS200 substrate was not PME pretreated and the combined substrates thus proved impossible to gel. [0212]
    TABLE II
    Effect of combined pectin substrates and calcium on
    gel strength achieved
    Calcium Relative Solidified
    Pectin % Soluble Plant PME Citrate Gel Strength Increase in Gel
    Type % Pectin Solids pH treated mash (5 mM) (N) Gel Strength Yes/No
    Mash 0 0.175 100 No
    SS200 0.8 20 3.1 + 0 0.195 111 No
    SS200 0.8 20 3.2 + + 0.223 127 No
    P66 0.8 20 3.1 0 0.316 180 Viscous
    P66 0.8 20 3.1 + + 0.457 312 Yes
    P60 0.8 20 3.1 0 0.530 302 Yes
    P60 0.8 20 3.1 + + 0.782 446 Yes
  • A solidified gel was obtained after combining the P66 pectin substrate with plant PME modified orange mash in the presence but not in the absence of calcium. In contrast, solidified gels were induced after combining the P60 pectin substrate with plant PME modified mash either in the presence or absence of calcium. [0213]
  • The additive effect of both PME treatment and the presence of calcium on pectin gelation is illustrated in FIG. 2. This figure sets out the percentage relative increase in gel strength (or hardness) observed when a P66 pectin substrate is added to either untreated or PME treated orange mash in the presence and absence of calcium. The actual values for gel strength (N) are shown next to each column and the percentage relative increase in gel strength is shown on the top of each column. Reading the figure from left to right, column one indicates that the untreated orange mash has a low gel strength which, on visual inspection, is in a liquid form. When a second pectin substrate, such as P66, is added to the untreated orange mash in the absence of calcium, there is no effect on the gel strength obtained (column 2). However, if P66 is added to plant PME treated orange mash an increase in gel viscosity is observed column 3). A similar increase in gel viscosity is observed by combining P66 with the untreated orange mash in the presence of calcium (column 4). Finally, if P66 is added to plant PME treated orange mash in the presence of calcium, a solidified gel is obtained (column 5). These results are obtained regardless of the sequence in which the combination and PME treatment of the substrates takes place. Thus, a solidified gel is obtained if a GRINSTED™ URS pectin substrate and an orange mash preparation are combined and PME treated in the presence of calcium or if a GRINSTED™ URS pectin substrate and an orange mash preparation are PME pretreated seperately before combination in the presence of calcium. [0214]
  • The experiments described in FIGS. 1 and 2 were repeated and the results are set out in Table III. A visual inspection of the gels produced from these experiments confirmed the earlier findings that: [0215]
  • (i) orange mash alone or after treatment with plant PME and calcium, either alone or in combination, will not induce an increase in gel strength. [0216]
  • (ii) The addition of calcium alone to GRINSTED™ URS pectin does not change the functionality of the pectin. Likewise, if GRINSTED™ URS pectin is not treated with plant PME, an increase in viscosity, but no solidification is observed when it is combined with plant PME treated orange mash either in the presence or absence of calcium. [0217]
  • (iii) The treatment of GRINSTED™ URS pectin with plant PME produces P66 which makes the pectin more functional when combined with plant PME treated orange mash in the presence of calcium. This increased functionality is indicated by the induction of solidification in the gel sample. [0218]
  • (iv) The treatment of two pectin substrates, such as orange mash and GRINSTED™ URS pectin with plant PME results in more functional high ester pectins, which in the presence of calcium, are capable of inducing solidification of a low solid jam. [0219]
    TABLE III
    Effect of combined pectin substrates and calcium
    on observed gel strength
    Plant PME
    % treated/ Calcium
    Pectin Plant % Soluble untreated Citrate
    Type PME Pectin Solids (+/−) mash) (5 mM) Gel State
    Mash
    0 0 Liquid
    Mash + + Liquid/
    Viscous
    Mash
    0 + Liquid
    Mash + + Liquid/
    Viscous
    URS* 0 0.8 20 0 Liquid
    URS* 0 0.8 20 + Liquid/
    Viscous
    URS* 0 0.8 20 + 0 Liquid/
    Viscous
    URS* 0 0.8 20 + + Liquid/
    Viscous
    P66 0.8 20 0 Viscous
    P66 0.8 20 + Viscous
    P66 0.8 20 + 0 Solidified
    P66 0.8 20 + Solidified
  • DISCUSSION [0220]
  • When a low soluble solid jam is prepared from an orange mash homogenate, no gelling is observed even after plant PME treatment or the addition of exogenous calcium. Likewise, if a second high ester pectin substrate, such as P66, is added to an untreated orange mash preparation, it will have no effect on its gelling capability even if the second pectin substrate is made more functional by pretreating it with a plant PME enzyme. An increase in gel viscosity will be observed, however, if a second high ester pectin substrate, such as P66, is combined with untreated orange mash in the presence of calcium. A similar effect, in terms of an increase in gel viscosity, is observed if the same high ester pectin substrate (P66; is combined with plant PME treated orange mash in the absence of calcium. [0221]
  • These results indicate that increases in gel viscosity can be induced by either plant PME treatment of orange mash prior to combination with a high ester pectin substrate such as P66 or by combining untreated orange mash with P66 in the presence of calcium. The results also indicate that the combination of plant PME treated orange mash with P66 in the presence of calcium will result in a solidified gel. This effect is obtained regardless of the sequence in which the combination and PME treatment of the substrates takes place. Thus, gel solidification will be observed by either PME pretreatment of the pectin substrates before combination or by PME treatment of the combined substrates in the presence of calcium. [0222]
  • SUMMARY
  • When a low soluble solid jam is prepared from orange mash, no gelling is observed even after the plant PME treatment of the orange mash or the addition of exogenous calcium. [0223]
  • If a second high ester pectin substrate is added to an untreated orange mash, it will have no effect on its gelling capability even if the second substrate is made more functional prior to addition by pretreatment with a plant PME enzyme. [0224]
  • The combination of plant PME treated orange mash with PME pretreated high ester pectin substrates, either in the presence or absence of calcium, will produce gels with substantially increased gel strength and improved functionality. Thus, PME treatment of pectin substrates, either alone or in combination, will improve their gelling capability by making the pectin substrates more functional as high ester substrates in the presence of calcium. [0225]
  • SEQUENCES [0226]
  • SEQ.I.D. NO. 1 [0227]
    MIKNMTDTDM MIMRTSNNRK LIEETSTVDG WPAWLSTGDR RLLQSSSVTP  50
    NVVVAADGSG NFKTVAAAVA AAPQGGTKRY IIRIKAGVYR ENVEVTKKHK 100
    NIMFIGDGRT RTIITGSRNV VDGSTTFKSA TVAVVGEGFL ARDITFQNTA 150
    GPSKHQAVAZ RVGADLSAFY NCDMLAYQDT LYVHSNRQFF VNCLIAGTVD 200
    FIFGNAAAVL QNCDIHARKP NSGQKNMVTA QGRADPNQNT GIVIQKSRIG 250
    ATSDLKPVQG SFPTYLGRPW KEYSRTVIMQ SSITDVIHPA GWHEWDGNFA 300
    LNTLFYGEHQ NAGAGAGTSG RVKWKGFRVI TSATEAQAFT PGSFIAGSSW 350
    LGSTGFPFSL GL 362
  • SEQ.I.D. NO. 2 [0228]
    MTRIKEFFTK LSESSTNQNI SNIPKKKKKL FLALFATLLV VAAVIGIVAG  50
    VNSRKNSGDN GNEPHHAILK SSCSSTRYPD LCFSAIAAVP EASKKVTSQK 100
    DVIEMSLNIT TTAVEHNYFG IQKLLKRTNL TKREKVALHD CLETIDETLD 150
    ELHKAVEDLE EYPNKKSLSQ HADDLKTLMS AAMTNQGTCL DGFSHDDANK 200
    HVRDALSDGQ VHVEKMCSNA LAMIKNMTDT DMMIMRTSNN RKLIEETSTV 250
    DGWPAWLSTG DRRLLQSSSV TPNVVVAADG SGNFKTVAAS VAAAPQGGTK 300
    RYIIRIKAGV YRENVEVTKK HKNIMFIGDG RTRTIITGSR NVVDGSTTFK 350
    SATVAVVGEG FLARDITFQN TAGPSKHQAV ALRVGADLSA FYNCDMLAYQ 400
    DTLYVHSNRQ FFVNCLIAGT VDFIFGNAAA VLQNCDIHAR KPNSGQKNMV 450
    TAQGRADPNQ NTGIVIQKSR IGATSDLKPV QGSFPTYLGR PWKEYSRTVI 500
    MQSSITDVIH PAGWHEWDGN FALNTLFYGE HQNAGAGAGT SGRVKWKGFR 550
    VITSATEAQA FTPGSFIAGS SWLGSTGFPF SLGL 584
  • SEQ.I.D. NO. 3 [0229]
    GTAGCAATGC GCTTGCTATG ATCAAGAACA TGACTGACAC TGACATGATG   50
    ATCATGAGGA CTTCAAACAA CAGGAAGCTG ATAGAGGAGA CCAGTACGGT  100
    TGATGGGTGG CCGGCGTGGC TGTCCACCGG AGACAGGAGG CTGTTGCAGT  150
    CCTCGTCGGT GACACCGAAC GTGGTGGTGG CAGCAGATGG CAGCGGAAAC  200
    TTTAAGACGG TGGCGGCAGC GGTGGCGGCG GCTCCTCAGG GAGGCACTAA  250
    GCGGTATATT ATTAGGATTA AAGCCGGTGT TTATCGGGAA AATGTTGAGG  300
    TGACAAAGAA GCATAAAAAT ATAATGTTCA TCGGTGACGG GAGGACTAGA  350
    ACTATCATCA CAGGAAGTAG AAATGTGGTT GATGGAAGCA CAACTTTCAA  400
    GTCTCCTACA GTTGCTGTTG TTGGTGAAGG ATTCTTGGCC CGAGACATTA  450
    CATTCCAAAA CACAGCCGGC CCCTCAAAGC ACCAGGCGGT GGCACTACGA  500
    GTGGGAGCTG ACCTTTCAGC ATTTTACAAT TGCGATATGT TAGCTTACCA  550
    AGACACACTC TACGTCCACT CGAACCGCCA GTTCTTTGTG AACTGCTTAA  600
    TTGCTGGCAC GGTTGATTTT ATTTTTGGTA ACGCTGCAGC CGTGTTACAA  650
    AATTGTGACA TCCATGCAAG AAAGCCCAAT TCCGGCCAAA AAAATATGGT  700
    CACAGCCCAA GGCAGGGCTG ACCCTAACCA AAACACCGGC ATTGTCATTC  750
    AAAAATCTAG GATTGGTGCC ACCTCCGATT TAAAACCGGT TCAGGGTAGT  800
    TTCCCGACGT ACCTCGGCAG GCCCTGGAAG GAGTACTCGA GGACGGTGAT  850
    CATGCAGTCA TCGATTACTG ACGTGATCCA CCCTGCCGGG TGGCACGAGT  900
    GGGATGGTAA CTTCGCGTTG AACACATTGT TTTACGGAGA GCATCAGAAC  950
    GCCGGAGCCG GTGCCGGAAC TTCAGGGAGA GTGAAATGGA AGGGATTTAG 1000
    GGTTATTACA AGTGCTACCG AGGCTCAAGC TTTTACTCCT GGAAGCTTCA 1050
    TTGCTGGTAG TAGCTGGCTG GGCTCCACTG GTTTCCCATT CTCCCTTGGT 1100
    TTGTAATATT CACTAGGAGT TTTAATTAAT ATGTTTTGTA TTAGTGGATC 1150
    CATAGGTCTC TGGTCTTTCA ATTTGTAATA TTTGATTGAG CGTGTCTTAT 1200
    TCGTGGCTTC GATTTCACAA ATACTATTGT GTGATTAACA AGAAATAAAA 1250
    TAGCATGGGA AGAATAATAA TTTCCGGCTT CTTTAAAAAA AAAAAAAAAA 1300
    AAAAAAAAAA AAAAAAAAAA AAA 1323
  • SEQ.I.D. NO. 4 [0230]
    CTTTTGTTCT CTCTTATCGA GAAAAAAAAT GACCCGCATA AAAGAATTCT   50
    TCACAAAACT TTCTGAATCT TCTACCAACC AAAACATTTC CAATATTCCC  100
    AAGAAAAAAA AGAAACTATT CTTAGCTCTT TTTGCAACGC TACTCGTTGT  150
    CGCTGCCGTA ATCGGCATTG TCGCCGGAGT GAACTCAAGA AAAAACTCCG  200
    CCGACAACGG CAACGAGCCT CATCATGCTA TCCTCAAATC ATCATGTAGC  250
    AGCACAAGGT ACCCGGACTT ATGCTTTTCG GCTATTGCTG CCGTTCCAGA  300
    GGCCTCCAAA AAGGTGACAA GCCAAAAGGA CGTTATTGAG ATGTCCTTAA  350
    ACATCACAAC AACAGCCGTG GAACACAACT ACTTCGGGAT TCAGAAGCTC  400
    TTGAAGAGAA CGAATCTCAC CAAACGGGAA AAGGTTGCTC TCCATGACTG  450
    TCTTGAGACG ATCGATGAGA CTCTTGATGA GTTACACAAA GCCGTCGAGG  500
    ATCTTGAGGA GTACCCGAAC AAGAAATCTT TATCACAGCA TGCGGATGAT  550
    CTCAAAACCC TAATGAGTGC CGCGATGACC AATCAGGGGA CGTGTCTTGA  600
    TGGGTTCTCT CATGATGATG CTAATAAGCA CGTGCGGGAT GCGTTGTCAG  650
    ACGGCCAGGT TCATGTTGAG AAGATGTGTA GCAATGCGCT TGCTATGATC  700
    AAGAACATGA CTGACACTGA CATGATGATC ATGACGACTT CAAACAACAG  750
    GAAGCTGATA GAGGAGACCA GTACGGTTGA TGGGTGGCCG GCGTGGCTGT  800
    CCACCGGAGA CAGGAGGCTG TTGCAGTCCT CGTCGGTGAC ACCGAACGTG  850
    GTGGTGGCAG CAGATGGCAG CGGAAACTTT AAGACGGTGG CGGCATCGGT  900
    GGCGGCGGCT CCTCAGGGAG GCACTAAGCG GTATATTATT AGGATTAAAG  950
    CCGGTGTTTA TCGGGAAAAT GTTGAGGTGA CAAAGAAGCA TAAAAATATA 1000
    ATGTTCATCG GTGACGGGAG GACTAGAACT ATCATCACAG GGAGTAGAAA 1050
    TGTGGTTGAT GGAAGCACAA CTTTCAAGTC TGCTACAGTT GCTGTTGTTG 1100
    GTGAAGGATT CTTGGCCCGA GACATTACAT TCCAAAACAC AGCCGGCCCC 1150
    TCAAAGCACC AGGCGGTGGC ACTACGAGTG GGAGCTGACC TTTCAGCATT 1200
    TTACAATTGC GATATGTTAG CTTACCAAGA CACACTCTAC GTCCACTCGA 1250
    ACCGCCAGTT CTTTGTGAAC TGCTTAATTG CTGGCACGGT TGATTTTATT 1300
    TTTGGTAACG CTGCAGCCGT GTTACAAAAT TGTGACATCC ATGCACGAAA 1230
    GCCCAATTCC GGCCAAAAAA ATATGGTCAC AGCCCAAGGC AGGGCTGACC 1400
    CTAACCAAAA CACCGGCATT GTCATTCAAA AATCTAGGAT TGGTGCCACC 1450
    TCCGATTTAA AACCGGTTCA GGGTAGTTTC CCGACGTACC TCGGCAGGCC 1500
    CTGGAAGGAG TACTCGAGGA CGGTGATCAT GCAGTCATCG ATTACTGACG 1550
    TGATCCACCC TGCCGGGTGG CACGAGTGGG ATGGTAACTT CGCGTTGAAC 1600
    ACATTGTTTT ACGGAGAGCA TTAGAACGCC GGAGCCGGTG CCGGAACTTC 1650
    AGGGAGAGTT AAATGGAAGG GATTTAGGGT TATTACAAGT GCTACCGAGG 1700
    CTCAAGCTTT TACTCCTGGA AGCTTCATTG CTGGTAGTAG CTGGCTGGGC 1750
    TCCACTGGTT TCCCATTCTC CCTTGGTTTG TAATATTCAC TAGGAGTTTT 1800
    AATTAATATG TTTTGTATTA GTGGATCCAT AGGTCTCTGG TCTTTCAATT 1850
    TGTAATATTT GATTGAGCGT GTCTTATTCG TGGCTTCGAT TTCACAAATA 1900
    CTATTGTGTG ATTAACAAGA AATAAAATAG CATGGGAAGA ATAATAATTT 1950
    CTGGCTTCTT TAAATTAAAA AAAAA 1975

Claims (18)

1. A gelling composition comprising a pectin methyl esterase (PME), a PME substrate; and a PME-treated pectin or derivative thereof; wherein neither the PME substrate nor the pectin originates in situ from the other.
2. A composition according to claim 1 wherein the PME is recombinant.
3. A composition according to claim 1 or claim 2 wherein the PME substrate is pectin or a derivative thereof.
4. A composition according to any one of the preceding claims wherein the PME substrate is present within a plant and/or a plant material.
5. A composition according to claim 4 wherein the plant or plant material is any one or more of a vegetable, a vegetable material, a fruit, or a fruit material.
6. A composition according to claim 5 wherein the vegetable material and/or the fruit material is a mash.
7. A composition according to any one of the preceding claims wherein the PME-treated pectin or derivative thereof is a high ester pectin.
8. A composition according to any one of the preceding claims wherein the PME substrate is a high ester substrate.
9. A composition according to any one of the preceding claims being in a solidified gel state and having a soluble solids content of less than 50% w/w.
10. A composition according to any one of the preceding claims wherein the composition is a foodstuff or is used in the preparation of a foodstuff.
11. A method of preparing a composition comprising a PME substrate and a PME-treated pectin or derivative thereof, the method comprising treating a PME substrate and a pectin or derivative thereof with PME prior to, during, and/or after combining said substrate and pectin or derivative thereof to form the composition; wherein neither the PME substrate nor the pectin or derivative thereof originates in situ from the other.
12. A method according to claim 11 wherein the PME is recombinant
13. A method according to claim 11 or claim 12 wherein the PME substrate is as defined in any one of claims 3 to 6.
14. A method according to any one of claims 11 to 13 wherein the method is for the preparation of a foodstuff.
15. A method of imparting stability to a reaction medium comprising a PME substrate, which process comprises adding at least a PME and a pectin or derivative thereof; wherein neither the PME substrate nor the pectin or derivative thereof originates in situ from the other.
16. A method according to claim 15 wherein the reaction medium is or is for preparing a foodstuff.
17. A composition obtainable by the method of any one of claims 11 to 13.
18. A composition according to claim 17 being in a solidified gel state and having a soluble solids content of less than 50% w/w.
US09/403,345 1997-04-24 1998-04-24 Composition comprising pectin methyl esterase and two substrates Expired - Lifetime US6368642B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9708278.8A GB9708278D0 (en) 1997-04-24 1997-04-24 Composition
GB9708278.8 1997-04-24
GB9708278 1997-04-24
PCT/IB1998/000673 WO1998047391A1 (en) 1997-04-24 1998-04-24 Composition comprising pectin methyl esterase and two substrates

Publications (2)

Publication Number Publication Date
US20020015758A1 true US20020015758A1 (en) 2002-02-07
US6368642B2 US6368642B2 (en) 2002-04-09

Family

ID=10811265

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/403,345 Expired - Lifetime US6368642B2 (en) 1997-04-24 1998-04-24 Composition comprising pectin methyl esterase and two substrates

Country Status (13)

Country Link
US (1) US6368642B2 (en)
EP (1) EP0977495B1 (en)
JP (1) JP2001519653A (en)
CN (1) CN1126460C (en)
AT (1) ATE307494T1 (en)
AU (1) AU6932498A (en)
BR (1) BR9808974A (en)
CA (1) CA2286479A1 (en)
DE (1) DE69832060T2 (en)
DK (1) DK0977495T3 (en)
GB (2) GB9708278D0 (en)
NZ (1) NZ500031A (en)
WO (1) WO1998047391A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2428365A (en) * 2005-07-22 2007-01-31 Mars Inc Fruit snack made from a gelled natural fruit pulp and a method of its manufacture
US20080014303A1 (en) * 2005-07-22 2008-01-17 Mars Incorporated Fruit Snack
US9910681B2 (en) 2007-08-01 2018-03-06 Microsoft Technology Licensing, Llc Instance interfaces and mix-ins for dynamic languages

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69809566T2 (en) * 1997-09-01 2003-07-10 Unilever Nv METHOD FOR TREATING FRUIT OR VEGETABLE BASED FOOD PRODUCTS WITH PECTIN METHYLESTERASE AND ADDED PECTIN
GB9817805D0 (en) * 1998-08-14 1998-10-14 Danisco Use of a composition
CA2370539C (en) 1999-04-23 2009-01-06 Massachusetts Institute Of Technology System and method for notating polymers
EP2538793A4 (en) * 2010-02-26 2014-07-23 Novozymes As Enzymatic pretreatment for making dried fruits
CN110564738B (en) * 2019-09-23 2022-07-26 中国农业科学院郑州果树研究所 Application of sweet cherry PaPME2 gene in regulating and controlling ripening or softening of sweet cherry fruits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365223A (en) 1991-10-28 1994-11-15 Honeywell Inc. Fail-safe condition sensing circuit
ATE140594T1 (en) * 1991-11-14 1996-08-15 Gist Brocades Nv METHOD FOR PRODUCING JUICES FROM FRUITS AND VEGETABLES
IL107791A (en) 1992-11-30 1997-04-15 Gist Brocades Nv Use of pectinesterase in the treatment of fruit and vegetables
US5707847A (en) 1993-04-30 1998-01-13 Novo Nordisk A/S Enzyme exhibiting pectin methylesterase activity
US5540813A (en) 1994-01-19 1996-07-30 Fina Technology, Inc. Method for reducing volatiles in polymerized styrene
GB9514438D0 (en) 1995-07-14 1995-09-13 Danisco Stabilisation process and an enzyme for use in such a process
ES2219752T3 (en) * 1996-02-21 2004-12-01 Novozymes A/S ENZYM WITH PECTIN ESTERASE ACTIVITY.

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2428365A (en) * 2005-07-22 2007-01-31 Mars Inc Fruit snack made from a gelled natural fruit pulp and a method of its manufacture
US20080014303A1 (en) * 2005-07-22 2008-01-17 Mars Incorporated Fruit Snack
GB2428365B (en) * 2005-07-22 2009-04-01 Mars Inc Fruit snack
US8586121B2 (en) 2005-07-22 2013-11-19 Mars, Inc. Fruit snack
US9910681B2 (en) 2007-08-01 2018-03-06 Microsoft Technology Licensing, Llc Instance interfaces and mix-ins for dynamic languages

Also Published As

Publication number Publication date
EP0977495A1 (en) 2000-02-09
GB9924715D0 (en) 1999-12-22
GB2339135B (en) 2001-08-22
AU6932498A (en) 1998-11-13
BR9808974A (en) 2000-08-01
GB2339135A (en) 2000-01-19
ATE307494T1 (en) 2005-11-15
WO1998047391A1 (en) 1998-10-29
DE69832060D1 (en) 2005-12-01
CA2286479A1 (en) 1998-10-29
DK0977495T3 (en) 2006-03-13
DE69832060T2 (en) 2006-07-20
JP2001519653A (en) 2001-10-23
CN1260687A (en) 2000-07-19
NZ500031A (en) 2001-03-30
EP0977495B1 (en) 2005-10-26
GB9708278D0 (en) 1997-06-18
CN1126460C (en) 2003-11-05
US6368642B2 (en) 2002-04-09

Similar Documents

Publication Publication Date Title
AU714570B2 (en) Process for stabilizing proteins in an acidic environment with a high-ester pectin
US6368642B2 (en) Composition comprising pectin methyl esterase and two substrates
AU760118B2 (en) Process for enzymatically modifying pectin
AU6923996A (en) Method for reducing the serum separation in a pectin containing aqueous mass
MXPA99009761A (en) Composition comprising pectin methyl esterase and two substrates
CZ374399A3 (en) Preparation containing pectin-methylesterase and two substrates
AU759012B2 (en) Amino acid sequence
EP1115873A1 (en) Orange fruit pectinacetylesterase

Legal Events

Date Code Title Description
AS Assignment

Owner name: DANISCO A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KREIBERG, JETTE DINA;CHRISTENSEN, TOVE MARTEL IDA ELSA;HYTTEL, SUSANNE;REEL/FRAME:010549/0723;SIGNING DATES FROM 19991203 TO 19991216

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: DUPONT NUTRITION BIOSCIENCES APS, DENMARK

Free format text: CHANGE OF NAME;ASSIGNOR:DANISCO A/S;REEL/FRAME:031035/0463

Effective date: 20120514

FPAY Fee payment

Year of fee payment: 12